site aa pred_sec pred_expbur pred_accessibility pdb_asym_id hetero nucleotide compound metal otherpoly homo precipitant A C D E F G H I K L M N P Q R S T V W Y feature_table variant 1 M 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 2 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 78 22 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 3 S 0 0 0 0 0 81 0 0 0 0 0 0 0 0 0 19 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 4 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 5 S 0 0 0 0 61 0 0 0 0 0 0 0 0 0 0 39 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 6 W 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 7 L 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 8 L 0 0 0 0 0 0 0 23 0 54 0 0 23 0 0 0 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 9 L 0 0 0 0 0 0 23 0 0 77 0 0 0 0 0 0 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 10 S 23 0 0 0 0 23 0 0 0 0 0 0 0 0 0 54 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 11 L 0 0 0 0 21 23 0 0 0 56 0 0 0 0 0 0 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 12 V 14 0 0 0 0 0 0 0 0 17 0 0 0 0 0 18 0 52 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 13 A 66 0 0 0 0 0 0 0 0 17 18 0 0 0 0 0 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 14 V 0 0 0 15 0 15 0 0 0 13 0 0 0 0 0 0 0 57 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 15 T 7 12 0 0 0 0 0 0 0 0 0 15 0 0 0 15 51 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 16 A 48 0 0 0 0 0 12 0 0 0 0 0 0 12 0 15 13 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 17 A 05B04 Light Chain[214 aa] 58 15 0 0 0 12 0 0 0 0 0 0 0 0 0 0 15 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 18 Q e 94.9 7v61_B SPIKE_SARS2:Spike protein S1[195 aa]:3E8[223 aa]:05B04 Light Chain[214 aa] 12 0 0 0 0 0 0 15 0 12 0 0 0 46 0 15 0 0 0 0 TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Extracellular" 19 S e 48.4 7v61_B SPIKE_CVHSA:D9IEJ2_BPT4:SPIKE_SARS2:A0A6B9WHD3_SARS:SPIKE_SARS:WAC_BPT4:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1080 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[144 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[194 aa]:h11B11-Fab[210 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1016 aa]:Spike glycoprotein[1008 aa]:Spike protein S1[185 aa]:Spike protein S1[192 aa]:Spike glycoprotein[997 aa]:Spike glycoprotein[1029 aa]:Spike glycoprotein[1030 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike protein S1[200 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[622 aa]:Spike glycoprotein[998 aa]:Spike protein S1[187 aa]:Spike protein S1[184 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[197 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:3E8[214 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[196 aa]:Spike glycoprotein[1060 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[194 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[186 aa]:Spike glycoprotein[1048 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike glycoprotein[1042 aa]:Spike glycoprotein[1097 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:05B04 Light Chain[214 aa]:Spike protein S1[162 aa]:Spike protein S1[167 aa]:Spike protein S2' [167 aa]:Spike protein S2' [183 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[1005 aa]:Spike glycoprotein[199 aa]:Spike protein S1[193 aa]:Spike glycoprotein[962 aa]:Spike glycoprotein[993 aa]:Spike glycoprotein[992 aa]:Spike glycoprotein[991 aa]:Spike protein S1[172 aa]:Spike protein S2' [196 aa]:Spike glycoprotein,Spike glycoprotein,Spike glycop.. 12 0 0 0 0 0 0 0 0 11 0 0 0 0 0 59 9 9 0 0 MUTAGEN:/note="S->P: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="S->P: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DISORDER:predicted by DISOPRED:DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 20 T H e 66.2 7v61_B SPIKE_SARS2:h11B11-Fab[210 aa]:3E8[223 aa]:3E8[214 aa]:Spike glycoprotein[1060 aa]:Spike glycoprotein[1032 aa]:05B04 Heavy Chain[218 aa]:05B04 Light Chain[214 aa]:Spike glycoprotein,Spike glycoprotein,Spike glycop..:Spike glycoprotein[1066 aa] 0 0 0 0 0 0 0 0 17 10 0 11 0 0 0 12 51 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 21 I H b 13.5 7v61_B SPIKE_SARS2:h11B11-Fab[210 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[1060 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1032 aa]:05B04 Light Chain[214 aa]:Spike glycoprotein,Spike glycoprotein,Spike glycop.. 0 0 27 17 0 0 0 14 0 0 0 0 0 0 0 0 30 12 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 22 E H b 11.1 7v61_B NAG 0 0 0 92 0 0 0 0 0 8 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 23 E H e 45.7 7v61_B SPIKE_SARS2:SPIKE_SARS:Spike glycoprotein[1080 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[195 aa]:h11B11-Fab[208 aa]:h11B11-Fab[210 aa]:Spike glycoprotein[997 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[1029 aa]:Spike glycoprotein[1030 aa]:3E8[223 aa]:3E8[214 aa]:Spike glycoprotein[1060 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1062 aa]:Spike glycoprotein[1024 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1066 aa]:05B04 Heavy Chain[218 aa]:Spike glycoprotein[1011 aa]:Spike glycoprotein[993 aa]:Spike glycoprotein[991 aa]:Spike protein S1[172 aa] CL 34 0 0 45 0 0 0 12 0 0 0 0 0 0 0 7 3 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 24 Q H e 48.0 7v61_B SPIKE_CVHSA:D9IEJ2_BPT4:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:A0A6B9WHD3_SARS:SPIKE_SARS:M1E1E4_9HIV1:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:WAC_BPT4:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1080 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[144 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:h11B11-Fab[208 aa]:h11B11-Fab[210 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1016 aa]:Spike glycoprotein[1008 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[192 aa]:Spike glycoprotein[997 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1030 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1029 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike glycoprotein, Envelope glycoprotein fusion[1..:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[622 aa]:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:3E8[223 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[196 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1060 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[186 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike glycoprotein[1042 aa]:Spike glycoprotein[1045 aa]:Spike glycoprotein[1097 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:05B04 Heavy Chain[218 aa]:05B04 Light Chain[214 aa]:Spike protein S1[162 aa]:Spike glycoprotein,Envelope glycoprotein[1061 aa]:Spike glycoprotein[676 aa]:Spike protein S2' [167 aa]:Spike protein S2' [181 aa]:Spike protein S2' [183 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1011 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[185 aa]:Spike glycoprotein[962 aa]:PRD-0038[174 aa]:Spike glycoprotein[1047 aa]:Spike glycoprotein[993 aa]:Spike glycoprotein[992 aa]:Spike glycoprotein[991 aa]:Spike protein S1[172 aa]:Spike protein S2' [196 aa]:Spike glycoprotein,Spike glycoprotein,Spike glycop.. 1 0 7 14 0 11 0 0 24 7 0 4 0 23 0 1 0 6 0 0 MUTAGEN:/note="Q->T: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":MUTAGEN:/note="QAK->KAE: Slightly inhibits interaction with SARS- CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="Q->T: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":MUTAGEN:/note="QAK->KAE: Slightly inhibits interaction with SARS- CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 25 A H b 0.0 7v61_B SPIKE_SARS2:h11B11-Fab[208 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1032 aa] 86 0 0 0 0 0 0 0 0 14 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="A->V: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":MUTAGEN:/note="QAK->KAE: Slightly inhibits interaction with SARS- CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="A->V: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":MUTAGEN:/note="QAK->KAE: Slightly inhibits interaction with SARS- CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 26 K H e 34.4 7v61_B SPIKE_SARS2:Spike glycoprotein[1066 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1024 aa]:05B04 Heavy Chain[218 aa]:Spike glycoprotein[954 aa] NAG:NDG CL beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b..:alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. 0 0 3 6 0 0 0 0 38 0 0 3 0 6 22 10 6 5 0 0 MUTAGEN:/note="QAK->KAE: Slightly inhibits interaction with SARS- CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="QAK->KAE: Slightly inhibits interaction with SARS- CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" K->R:LB/B:rs4646116: -; 27 T H e 49.4 7v61_B SPIKE_CVHSA:D9IEJ2_BPT4:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:A0A6B9WHD3_SARS:SPIKE_SARS:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:WAC_BPT4:M1E1E4_9HIV1:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1080 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[144 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:h11B11-Fab[208 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1016 aa]:Spike glycoprotein[1008 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[192 aa]:Spike glycoprotein[997 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1030 aa]:Spike glycoprotein[1029 aa]:Spike glycoprotein[1031 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[622 aa]:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:3E8[223 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[196 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1060 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[186 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike glycoprotein[1042 aa]:Spike glycoprotein[1045 aa]:Spike glycoprotein[1097 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:05B04 Heavy Chain[218 aa]:Spike protein S1[162 aa]:Spike glycoprotein,Envelope glycoprotein[1061 aa]:Spike glycoprotein[676 aa]:Spike protein S1[167 aa]:Spike protein S2' [167 aa]:Spike protein S2' [181 aa]:Spike protein S2' [183 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1011 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[1005 aa]:Spike glycoprotein[199 aa]:Spike glycoprotein[185 aa]:Spike glycoprotein[962 aa]:Spike glycoprotein[954 aa]:PRD-0038[174 aa]:Spike glycoprotein[1047 aa]:Spike glycoprotein[991 aa]:Spike protein S1[172 aa]:Spike protein S2' [196 aa]:Spike glycoprotein,Spike glycoprotein,Spike glycop.. CL GOL 0 0 0 12 5 0 0 6 13 7 0 0 0 0 21 18 19 0 0 0 MUTAGEN:/note="T->Y: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein. In sACE2.v2.2; increases interaction with RBD domain of SARS-CoV-2 spike protein; when associated with Y-330 and L-386.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="T->Y: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein. In sACE2.v2.2; increases interaction with RBD domain of SARS-CoV-2 spike protein; when associated with Y-330 and L-386.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 28 F H b 12.0 7v61_B SPIKE_CVHSA:D9IEJ2_BPT4:SPIKE_SARS2:A0A6G6A1M4_9BETC:A0A6B9WHD3_SARS:SPIKE_SARS:A0A6G6A2Q2_9BETC:WAC_BPT4:M1E1E4_9HIV1:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1080 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[144 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:h11B11-Fab[208 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1016 aa]:Spike glycoprotein[1008 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[192 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1029 aa]:Spike glycoprotein[1030 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[622 aa]:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Spike protein S1[184 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:3E8[223 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[196 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[186 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike glycoprotein[1042 aa]:Spike glycoprotein[1097 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:Spike glycoprotein[1045 aa]:05B04 Heavy Chain[218 aa]:Spike protein S1[162 aa]:Spike glycoprotein,Envelope glycoprotein[1061 aa]:Spike glycoprotein[676 aa]:Spike protein S1[167 aa]:Spike protein S2' [167 aa]:Spike protein S2' [181 aa]:Spike protein S2' [183 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1011 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[1005 aa]:Spike glycoprotein[199 aa]:Spike glycoprotein[185 aa]:Spike glycoprotein[962 aa]:PRD-0038[174 aa]:Spike glycoprotein[1047 aa]:Spike glycoprotein[993 aa]:Spike glycoprotein[992 aa]:Spike protein S2' [196 aa]:Spike glycoprotein,Spike glycoprotein,Spike glycop.. 0 0 0 0 68 0 0 0 0 0 0 0 0 0 0 0 0 0 21 12 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 29 L H b 2.8 7v61_B SPIKE_SARS2:Spike glycoprotein[1048 aa] CL beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. 11 0 0 0 8 0 0 0 0 62 0 0 0 0 0 0 0 19 0 0 MUTAGEN:/note="L->F: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="L->F: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 30 D H e 59.3 7v61_B SPIKE_CVHNL:SPIKE_CVHSA:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:A0A6B9WHD3_SARS:SPIKE_SARS:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:WAC_BPT4:M1E1E4_9HIV1:A0A7D6P0R3_9BETC:Spike glycoprotein[110 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[144 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:Spike glycoprotein[1016 aa]:Spike glycoprotein[1008 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[192 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1030 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1029 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[201 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[196 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1060 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[186 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1026 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike protein S1[162 aa]:Spike glycoprotein,Envelope glycoprotein[1061 aa]:Spike glycoprotein[676 aa]:Spike glycoprotein[1011 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[199 aa]:Spike glycoprotein[185 aa]:Spike glycoprotein[962 aa]:Spike glycoprotein[954 aa]:Spike glycoprotein[1047 aa]:Spike protein S2' [196 aa] NAG CL beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. 20 0 6 43 0 0 0 0 0 0 0 7 0 12 0 5 7 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 31 K H e 68.9 7v61_B SPIKE_CVHSA:D9IEJ2_BPT4:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:A0A6B9WHD3_SARS:SPIKE_SARS:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:WAC_BPT4:M1E1E4_9HIV1:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1080 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[144 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:h11B11-Fab[208 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1016 aa]:Spike glycoprotein[1008 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[192 aa]:Spike glycoprotein[997 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1029 aa]:Spike glycoprotein[1030 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[622 aa]:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:3E8[223 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[196 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1060 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[186 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike glycoprotein[1042 aa]:Spike glycoprotein[1045 aa]:Spike glycoprotein[1058 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:Spike protein S1[162 aa]:Spike glycoprotein,Envelope glycoprotein[1061 aa]:Spike glycoprotein[676 aa]:Spike protein S1[167 aa]:Spike protein S2' [167 aa]:Spike protein S2' [181 aa]:Spike protein S2' [183 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1011 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[1005 aa]:Spike glycoprotein[199 aa]:Spike glycoprotein[185 aa]:Spike glycoprotein[962 aa]:Spike glycoprotein[954 aa]:PRD-0038[174 aa]:Spike glycoprotein[1047 aa]:Spike glycoprotein[993 aa]:Spike glycoprotein[992 aa]:Spike glycoprotein[991 aa]:Spike protein S1[172 aa]:Spike protein S2' [196 aa]:Spike glycoprotein,Spike glycoprotein,Spike glycop.. EDO:GOL 0 0 0 25 7 14 0 0 16 8 0 15 0 0 0 6 10 0 0 0 MUTAGEN:/note="K->D: Abolishes interaction with SARS-CoV spike glycoprotein.":MUTAGEN:/note="K->Y: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="K->D: Abolishes interaction with SARS-CoV spike glycoprotein.":MUTAGEN:/note="K->Y: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 32 F H b 0.0 7v61_B BNP_GLOBL:SPIKE_SARS2:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[993 aa]:Spike glycoprotein[992 aa] PG0 PEG:EDO:PGE 0 0 0 8 28 0 0 6 0 6 0 0 0 0 0 0 0 0 0 52 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 33 N H b 20.0 7v61_B SPIKE_CVHNL:Spike glycoprotein[110 aa] NAG CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. EPE 0 0 19 21 0 0 0 0 0 0 0 60 0 0 0 0 0 0 0 0 MUTAGEN:/note="N->D: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="N->D: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 34 H H e 73.8 7v61_B SPIKE_CVHSA:SPIKE_CVHNL:D9IEJ2_BPT4:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:A0A6B9WHD3_SARS:SPIKE_SARS:M1E1E4_9HIV1:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:WAC_BPT4:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[110 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1080 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[144 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1016 aa]:Spike glycoprotein[1008 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[192 aa]:Spike glycoprotein[997 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1030 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1029 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike glycoprotein, Envelope glycoprotein fusion[1..:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[622 aa]:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:3E8[223 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[196 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1060 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[186 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike glycoprotein[1042 aa]:Spike glycoprotein[1045 aa]:Spike glycoprotein[1097 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:Spike protein S1[162 aa]:Spike glycoprotein,Envelope glycoprotein[1061 aa]:Spike glycoprotein[676 aa]:Spike protein S1[167 aa]:Spike protein S2' [167 aa]:Spike protein S2' [181 aa]:Spike protein S2' [183 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1011 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[1005 aa]:Spike glycoprotein[199 aa]:Spike glycoprotein[185 aa]:Spike glycoprotein[962 aa]:Spike glycoprotein[954 aa]:PRD-0038[174 aa]:Spike glycoprotein[1047 aa]:Spike glycoprotein[993 aa]:Spike glycoprotein[992 aa]:Spike glycoprotein[991 aa]:Spike protein S1[172 aa]:Spike protein S2' [196 aa]:Spike glycoprotein,Spike glycoprotein,Spike glycop.. NAG CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. EDO:PEG 14 0 7 8 0 0 13 0 12 0 0 0 0 13 19 11 0 0 0 3 MUTAGEN:/note="H->A: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="H->A: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 35 E H e 45.7 7v61_B SPIKE_CVHSA:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6B9WHD3_SARS:A0A7U0MIF7_SARS2:M1E1E4_9HIV1:A0A7D6P0R3_9BETC:Spike glycoprotein[173 aa]:Spike glycoprotein[174 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[1080 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1016 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1029 aa]:Spike glycoprotein[1030 aa]:Spike protein S1[203 aa]:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[250 aa]:Spike protein S1[187 aa]:Spike protein S1[184 aa]:Spike protein S1[185 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[197 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:3E8[223 aa]:Spike glycoprotein[196 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[201 aa]:RshSTT182/200 coronavirus receptor binding domain ..:Spike glycoprotein[1062 aa]:Spike glycoprotein[998 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1066 aa]:Spike glycoprotein[1097 aa]:Spike protein S1[166 aa]:Spike glycoprotein[1045 aa]:Spike glycoprotein,Envelope glycoprotein[1061 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[676 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1011 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[1005 aa]:Spike glycoprotein[199 aa]:Spike protein S1[192 aa]:Spike glycoprotein[962 aa]:Spike glycoprotein[185 aa]:PRD-0038[174 aa]:Spike glycoprotein[1047 aa]:Spike glycoprotein[992 aa]:Spike glycoprotein[991 aa]:Spike protein S2' [196 aa] ZN EDO:GOL 0 0 0 55 0 0 0 0 0 0 0 0 0 8 4 9 24 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 36 A H b 0.0 7v61_B PEG:EDO 70 0 0 0 3 0 0 0 0 20 0 0 0 0 0 7 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 37 E H b 12.1 7v61_B SPIKE_CVHSA:SPIKE_CVHNL:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:SPIKE_SARS:M1E1E4_9HIV1:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:WAC_BPT4:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[110 aa]:Spike glycoprotein[174 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1065 aa]:Spike protein S1[144 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[131 aa]:Spike protein S1[192 aa]:Spike glycoprotein[997 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[1030 aa]:Spike glycoprotein[1029 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike glycoprotein, Envelope glycoprotein fusion[1..:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[998 aa]:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1035 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike protein S1[188 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1060 aa]:Spike glycoprotein[198 aa]:Spike protein S1[186 aa]:Spike protein S1[190 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1024 aa]:Spike protein S1[198 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:Spike glycoprotein[676 aa]:Spike glycoprotein[196 aa]:Spike glycoprotein[185 aa]:Spike glycoprotein[962 aa]:PRD-0038[174 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. EPE:PEG:EDO 12 0 0 31 0 7 0 14 3 0 0 0 0 23 11 0 0 0 0 0 MUTAGEN:/note="E->A: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="E->A: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 38 D H e 53.7 7v61_B SPIKE_CVHSA:D9IEJ2_BPT4:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:A0A6B9WHD3_SARS:SPIKE_SARS:M1E1E4_9HIV1:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:WAC_BPT4:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[144 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[192 aa]:Spike glycoprotein[997 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1030 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1029 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike glycoprotein, Envelope glycoprotein fusion[1..:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[196 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[186 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike glycoprotein[1045 aa]:Spike glycoprotein[1042 aa]:Spike protein S1[193 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:Spike protein S1[162 aa]:Spike glycoprotein[676 aa]:Spike protein S1[167 aa]:Spike protein S2' [167 aa]:Spike protein S2' [181 aa]:Spike protein S2' [183 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1011 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[1005 aa]:Spike glycoprotein[199 aa]:Spike glycoprotein[962 aa]:Spike glycoprotein[954 aa]:PRD-0038[174 aa]:Spike glycoprotein[1047 aa]:Spike glycoprotein[993 aa]:Spike glycoprotein[992 aa]:Spike glycoprotein[991 aa]:Spike protein S1[172 aa]:Spike protein S2' [196 aa] CL EDO 3 0 17 6 0 0 0 5 32 0 0 0 0 6 8 0 0 23 0 0 MUTAGEN:/note="D->A: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="D->A: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 39 L H e 20.8 7v61_B SPIKE_SARS2:Spike glycoprotein[1048 aa] 0 0 0 0 0 0 6 0 0 32 0 0 0 0 14 0 0 42 0 7 MUTAGEN:/note="L->R: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="L->R: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 40 F H e 24.9 7v61_B BNP_GLOBL:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Bradykinin potentiating peptide b[11 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 1[13 aa]:Peptide 2[15 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] 3ES:PG0 CL PEG:P6G:EDO:GOL:PGE 0 0 0 0 14 0 0 7 0 38 0 0 0 0 0 17 12 0 13 0 MUTAGEN:/note="F->D: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="F->D: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 41 Y H b 20.0 7v61_B SPIKE_CVHSA:SPIKE_CVHNL:D9IEJ2_BPT4:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:A0A6B9WHD3_SARS:SPIKE_SARS:M1E1E4_9HIV1:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:WAC_BPT4:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[110 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1080 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[144 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1016 aa]:Spike glycoprotein[1008 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[131 aa]:Spike protein S1[192 aa]:Spike glycoprotein[997 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1030 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1029 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike glycoprotein, Envelope glycoprotein fusion[1..:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[622 aa]:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[196 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[186 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike glycoprotein[1042 aa]:Spike glycoprotein[1045 aa]:Spike glycoprotein[1097 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:Spike protein S1[162 aa]:Spike glycoprotein,Envelope glycoprotein[1061 aa]:Spike glycoprotein[676 aa]:Spike protein S1[167 aa]:Spike protein S2' [167 aa]:Spike protein S2' [181 aa]:Spike protein S2' [183 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1011 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[1005 aa]:Spike glycoprotein[199 aa]:Spike glycoprotein[185 aa]:Spike glycoprotein[962 aa]:Spike glycoprotein[954 aa]:PRD-0038[174 aa]:Spike glycoprotein[1047 aa]:Spike glycoprotein[993 aa]:Spike glycoprotein[992 aa]:Spike glycoprotein[991 aa]:Spike protein S1[172 aa]:Spike protein S2' [196 aa]:Spike glycoprotein,Spike glycoprotein,Spike glycop.. PEG:EDO:PG4 0 0 0 0 11 0 8 0 0 0 0 38 0 0 14 0 0 0 0 29 MUTAGEN:/note="Y->A: Strongly inhibits interaction with SARS-CoV spike glycoprotein.":MUTAGEN:/note="Y->R: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="Y->A: Strongly inhibits interaction with SARS-CoV spike glycoprotein.":MUTAGEN:/note="Y->R: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 42 Q H e 57.7 7v61_B SPIKE_CVHSA:D9IEJ2_BPT4:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:A0A6B9WHD3_SARS:SPIKE_SARS:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:WAC_BPT4:M1E1E4_9HIV1:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[144 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1016 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[192 aa]:Spike glycoprotein[997 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1029 aa]:Spike glycoprotein[1030 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[622 aa]:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[196 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[186 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike glycoprotein[1042 aa]:Spike glycoprotein[1097 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:Spike glycoprotein[1045 aa]:Spike protein S1[162 aa]:Spike glycoprotein,Envelope glycoprotein[1061 aa]:Spike glycoprotein[676 aa]:Spike protein S1[167 aa]:Spike protein S2' [167 aa]:Spike protein S2' [181 aa]:Spike protein S2' [183 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[1005 aa]:Spike glycoprotein[199 aa]:Spike glycoprotein[185 aa]:Spike glycoprotein[962 aa]:Spike glycoprotein[954 aa]:Spike glycoprotein[1047 aa]:Spike glycoprotein[991 aa]:Spike protein S1[172 aa]:Spike protein S2' [196 aa]:Spike glycoprotein,Spike glycoprotein,Spike glycop.. PGE 0 0 7 48 0 0 0 0 0 0 0 0 0 28 5 0 0 12 0 0 MUTAGEN:/note="Q->L: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="Q->L: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 43 S H b 15.6 7v61_B BNP_GLOBL:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Bradykinin potentiating peptide b[11 aa]:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 2[15 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] 3ES:FT8 EPE:ACT:PEG:P6G:IMD:PGE:EDO:BO3:GOL 7 0 0 20 7 0 0 0 0 0 0 0 0 0 0 34 0 14 0 19 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 44 S H b 11.7 7v61_B SPIKE_SARS2:Spike glycoprotein[1048 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 1[13 aa]:Peptide 2[15 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] 3ES:BCN PEG:P6G:PGE:GOL:EDO 34 0 0 0 8 0 0 0 0 0 7 0 0 0 0 23 24 5 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 45 L H e 20.2 7v61_B SPIKE_CVHSA:D9IEJ2_BPT4:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6B9WHD3_SARS:SPIKE_SARS:A0A7U0MIF7_SARS2:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike protein S1[194 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[194 aa]:Spike glycoprotein[195 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1024 aa]:Spike protein S1[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1030 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[251 aa]:Spike glycoprotein[622 aa]:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Spike protein S1[185 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[196 aa]:Spike protein S1[188 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike protein S1[190 aa]:RshSTT182/200 coronavirus receptor binding domain ..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1042 aa]:Spike protein S1[200 aa]:Spike protein S1[198 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:Spike glycoprotein[954 aa]:Spike glycoprotein[1061 aa]:Spike protein S1[172 aa]:Spike glycoprotein[1066 aa] NAG:BCN CL ACT:PEG:EDO 6 0 0 44 0 0 0 0 0 42 0 0 0 0 0 5 0 3 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 46 A H b 8.9 7v61_B NAG 72 0 0 0 0 0 0 0 0 0 0 0 0 0 0 22 0 6 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 47 S H e 23.4 7v61_B ANGT_HUMAN:ANGIOTENSIN-2[8 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 1[13 aa]:Peptide 2[15 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] 3ES:K26:FT8:LFI ACT:PEG:P6G:EDO:PGE:GOL 6 0 0 7 0 22 0 0 0 0 0 19 0 0 0 40 7 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 48 W H b 5.2 7v61_B NAG:BCN ACT:PEG 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 92 8 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 49 N H e 40.6 7v61_B NAG CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. ACT:PEG:EDO 17 0 4 5 0 0 3 0 0 0 0 50 0 6 14 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 50 Y H e 25.2 7v61_B ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 2[15 aa]:Cyclic peptide 2[15 aa] PGE:PEG:EDO 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 0 0 0 0 94 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 51 N H b 20.0 7v61_B ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 1[13 aa]:Peptide 2[15 aa]:Cyclic peptide 2[15 aa] LPR PEG 6 0 6 0 14 6 0 0 0 0 0 62 0 0 0 0 0 7 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 52 T H b 13.0 7v61_B NAG EDO:BO3 0 0 0 0 0 0 0 0 0 0 0 14 0 0 0 12 74 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 53 N S e 33.9 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b..:alpha-D-mannopyranose-(1-3)-2-acetamido-2-deoxy-be.. EDO 0 0 14 0 0 0 0 0 0 0 0 86 0 0 0 0 0 0 0 0 CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 54 I e 24.0 7v61_B NAG PEG:PGE:EDO 14 0 0 0 0 0 0 66 0 12 0 0 0 0 0 0 0 8 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 55 T e 26.6 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b..:alpha-D-mannopyranose-(1-3)-2-acetamido-2-deoxy-be.. PEG:PGE:EDO:SO4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14 86 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 56 E S e 72.9 7v61_B PEG:PGE:EDO:SO4 4 0 28 26 0 0 0 6 7 3 0 0 14 0 0 0 12 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 57 E T e 61.8 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b..:alpha-D-mannopyranose-(1-3)-2-acetamido-2-deoxy-be.. 13 0 0 60 0 0 7 0 0 0 0 0 0 7 0 14 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 58 N T b 10.3 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b..:alpha-D-mannopyranose-(1-3)-2-acetamido-2-deoxy-be.. EDO 7 0 0 0 0 10 0 0 0 14 0 66 0 0 0 0 3 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 59 V H e 28.7 7v61_B ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR.. PGE:EDO 16 0 0 12 0 0 0 0 14 7 0 0 0 7 8 20 0 13 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 60 Q H e 50.0 7v61_B 0 0 0 0 0 7 0 0 35 15 0 0 0 28 12 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 61 N H e 41.2 7v61_B NAG CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. EDO:PGE 22 0 0 0 0 0 0 23 19 12 0 16 0 0 4 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 62 M H b 19.3 7v61_B ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 1[13 aa]:Peptide 2[15 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] LFI 0 0 0 0 0 0 0 0 6 31 37 0 0 6 6 7 0 4 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 63 N H e 47.9 7v61_B ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 1[13 aa]:Cyclic peptide 2[15 aa] ACT:BO3:EDO 0 0 14 6 0 0 0 15 0 27 0 31 0 0 0 4 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 64 N H e 52.7 7v61_B PGE 0 0 0 63 0 0 0 0 7 0 0 7 0 20 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 65 A H b 17.0 7v61_B Peptide 2[15 aa]:Cyclic peptide 2[15 aa] PGE 48 0 0 0 0 0 0 12 33 0 0 0 0 0 0 0 0 8 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 66 G H e 21.4 7v61_B Bradykinin potentiating peptide b[11 aa]:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 1[13 aa]:Peptide 2[15 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] FT8 EPE:ACT:IMD:BO3 12 0 0 21 0 13 0 0 0 1 0 13 0 0 4 25 0 0 0 8 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 67 D H e 67.3 7v61_B ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR.. NAG 43 0 7 0 0 0 0 0 7 6 7 21 0 0 0 0 7 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 68 K H e 61.3 7v61_B PGE 0 0 13 18 0 0 0 0 26 1 0 0 0 16 8 0 0 15 0 0 MUTAGEN:/note="K->D: Slightly inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="K->D: Slightly inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 69 W H b 16.3 7v61_B BNP_GLOBL:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Bradykinin potentiating peptide b[11 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 1[13 aa]:Peptide 2[15 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] 3ES:LFI 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. EDO:BO3:GOL:PGE 0 0 0 0 0 0 0 7 0 27 4 14 0 0 7 0 0 15 23 0 MUTAGEN:/note="W->V: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="W->V: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 70 S H e 57.8 7v61_B Bradykinin potentiating peptide b[11 aa]:Peptide 1[13 aa]:Cyclic peptide 2[15 aa] 40 0 0 6 0 0 0 0 0 1 0 0 0 0 0 36 14 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 71 A H e 41.1 7v61_B NAG alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. 34 0 0 8 0 0 0 0 12 0 14 19 0 7 0 0 7 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 72 F H b 7.2 7v61_B SPIKE_SARS2:Spike glycoprotein[1011 aa] EDO 0 0 0 0 59 0 19 0 0 14 0 0 0 0 0 5 0 0 0 3 MUTAGEN:/note="F->Y: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="F->Y: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 73 L H e 32.0 7v61_B BNP_GLOBL:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Bradykinin potentiating peptide b[11 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 1[13 aa]:Peptide 2[15 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] ZN 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. EPE:EDO 0 0 0 0 0 0 0 0 0 23 12 8 0 0 0 0 26 14 0 17 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 74 K H e 57.5 7v61_B NAG alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. PG4 0 0 0 28 0 0 0 0 26 22 0 0 0 0 14 6 0 4 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 75 E H e 53.3 7v61_B SPIKE_SARS2:Spike glycoprotein[1011 aa] ZN alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. EDO 0 0 0 40 0 0 0 0 16 0 0 0 0 12 8 14 3 0 0 7 MUTAGEN:/note="E->K: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="E->K: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 76 Q H b 11.7 7v61_B SPIKE_SARS2:Spike glycoprotein[1032 aa]:Spike glycoprotein[1011 aa] EDO:GOL 0 0 0 6 7 0 0 0 7 8 0 0 0 28 0 0 14 12 0 19 MUTAGEN:/note="Q->T: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="Q->T: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 77 S H b 15.6 7v61_B alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. 26 0 0 0 6 19 0 0 0 0 0 5 0 0 0 44 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 78 T H e 55.2 7v61_B SPIKE_SARS2:Spike glycoprotein[1011 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. EDO:PG4 0 0 0 0 0 0 0 10 24 0 14 3 0 8 4 11 25 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 79 L G e 39.3 7v61_B SPIKE_CVHSA:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6B9WHD3_SARS:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:SPIKE_SARS:WAC_BPT4:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[1057 aa]:Spike protein S1[194 aa]:SARS-CoV-2 chimeric RBD[193 aa]:Spike glycoprotein[1080 aa]:Spike glycoprotein[1066 aa]:Spike glycoprotein[1068 aa]:Spike protein S1[195 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[194 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1030 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike protein S1[187 aa]:Spike protein S1[184 aa]:Spike protein S1[185 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[201 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[1032 aa]:Spike protein S1[198 aa]:Spike protein S1[197 aa]:Spike protein S1[188 aa]:3E8[223 aa]:Spike glycoprotein[1029 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1060 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike protein S1[186 aa]:Spike protein S1[190 aa]:RshSTT182/200 coronavirus receptor binding domain ..:Spike glycoprotein[1062 aa]:Spike glycoprotein[195 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[1042 aa]:Spike glycoprotein[1097 aa]:Spike glycoprotein[197 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1045 aa]:Spike protein S1[162 aa]:Spike glycoprotein[676 aa]:Spike glycoprotein[998 aa]:Spike glycoprotein[999 aa]:Spike glycoprotein[196 aa]:Spike glycoprotein[192 aa]:PRD-0038[174 aa]:Spike glycoprotein[1047 aa]:Spike glycoprotein[992 aa]:Spike glycoprotein[991 aa]:Spike protein S2' [196 aa] EDO:GOL 5 0 12 12 0 0 0 3 0 16 4 0 0 25 10 0 3 0 10 0 MUTAGEN:/note="L->T: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="L->T: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 80 A G b 0.0 7v61_B SPIKE_SARS2:Spike glycoprotein[1048 aa]:Spike glycoprotein[1032 aa] 75 0 0 0 0 0 0 14 5 0 0 0 0 0 0 0 6 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 81 Q G e 41.3 7v61_B SPIKE_SARS2:Spike glycoprotein[1032 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. EDO 0 0 0 5 0 0 0 0 45 0 0 0 0 22 17 0 6 0 6 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 82 M G e 63.8 7v61_B SPIKE_CVHSA:D9IEJ2_BPT4:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:A0A6B9WHD3_SARS:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:WAC_BPT4:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1080 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[144 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:h11B11-Fab[210 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1016 aa]:Spike glycoprotein[1008 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1029 aa]:Spike glycoprotein[1030 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[998 aa]:Spike protein S1[187 aa]:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[197 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:3E8[223 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[196 aa]:Spike glycoprotein[1060 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike glycoprotein[1061 aa]:RshSTT182/200 coronavirus receptor binding domain ..:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike glycoprotein[1062 aa]:Spike glycoprotein[1042 aa]:Spike glycoprotein[1045 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1097 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike protein S1[200 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:05B04 Heavy Chain[218 aa]:Spike protein S1[162 aa]:Spike glycoprotein[676 aa]:Spike protein S1[167 aa]:Spike protein S2' [167 aa]:Spike protein S2' [183 aa]:Spike protein S1[199 aa]:Spike glycoprotein[185 aa]:Spike protein S1[192 aa]:Spike glycoprotein[993 aa]:Spike glycoprotein[992 aa]:Spike glycoprotein[991 aa]:Spike protein S2' [196 aa]:Spike glycoprotein,Spike glycoprotein,Spike glycop.. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 0 0 0 0 6 0 0 28 5 13 3 0 14 3 11 16 0 0 0 MUTAGEN:/note="MYP->NFS: Inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="MYP->NFS: Inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 83 Y S b 11.7 7v61_B SPIKE_CVHSA:D9IEJ2_BPT4:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:A0A6B9WHD3_SARS:SPIKE_SARS:M1E1E4_9HIV1:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:WAC_BPT4:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1080 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[144 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:h11B11-Fab[208 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[192 aa]:Spike glycoprotein[997 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1030 aa]:Spike glycoprotein[1029 aa]:Spike glycoprotein[1031 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike glycoprotein, Envelope glycoprotein fusion[1..:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[622 aa]:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:3E8[223 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[196 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[186 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike glycoprotein[1042 aa]:Spike glycoprotein[1045 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1097 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:05B04 Heavy Chain[218 aa]:Spike protein S1[162 aa]:Spike glycoprotein,Envelope glycoprotein[1061 aa]:Spike glycoprotein[676 aa]:Spike protein S1[167 aa]:Spike protein S2' [167 aa]:Spike protein S2' [181 aa]:Spike protein S2' [183 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[1005 aa]:Spike glycoprotein[199 aa]:Spike glycoprotein[185 aa]:Spike glycoprotein[962 aa]:Spike glycoprotein[1047 aa]:Spike glycoprotein[993 aa]:Spike glycoprotein[992 aa]:Spike glycoprotein[991 aa]:Spike protein S1[172 aa]:Spike protein S2' [196 aa]:Spike glycoprotein,Spike glycoprotein,Spike glycop.. 0 0 0 0 65 0 0 0 0 0 0 0 0 6 0 8 0 0 0 22 MUTAGEN:/note="MYP->NFS: Inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="MYP->NFS: Inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 84 P e 45.0 7v61_B SPIKE_SARS2:Spike glycoprotein[1048 aa] beta-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(.. 0 0 42 0 0 5 0 0 6 0 0 6 13 6 7 10 0 7 0 0 MUTAGEN:/note="MYP->NFS: Inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="MYP->NFS: Inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 85 L S e 23.6 7v61_B SPIKE_SARS2:Spike glycoprotein[1048 aa] 6 0 0 0 0 0 0 0 0 23 14 0 0 0 0 0 7 19 23 8 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 86 Q T e 84.7 7v61_B ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa]:Processed angiotensin-converting enzyme 2[596 aa] PEG 24 0 7 4 0 0 0 0 12 0 0 3 0 13 12 18 0 8 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 87 E T e 28.6 7v61_B SPIKE_SARS2:Spike glycoprotein[1048 aa] 0 0 6 23 0 0 7 0 0 0 0 28 0 11 0 20 6 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 88 I b 0.0 7v61_B SPIKE_SARS2:Spike glycoprotein[1048 aa] NAG 0 0 0 0 31 0 0 26 0 9 0 0 0 0 0 8 0 14 0 12 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 89 Q e 77.6 7v61_B NDG:NAG 0 0 0 8 0 6 3 0 0 7 0 0 0 51 0 5 21 0 0 0 MUTAGEN:/note="Q->P: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="Q->P: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 90 N e 27.3 7v61_B NAG:NDG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b..:alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. 0 0 37 0 0 0 0 0 0 0 0 48 0 0 0 12 3 0 0 0 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:15084671, ECO:0000269|PubMed:19901337":MUTAGEN:/note="N->Q: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:15084671, ECO:0000269|PubMed:19901337":MUTAGEN:/note="N->Q: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 91 L H e 37.6 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 24 0 0 20 9 0 0 0 0 10 0 0 15 7 0 6 6 0 0 3 MUTAGEN:/note="L->P: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="L->P: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 92 T H e 34.4 7v61_B NAG:NDG beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b..:alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. 0 0 26 0 0 0 0 3 17 7 0 0 0 5 0 3 38 0 0 0 MUTAGEN:/note="T->Q: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="T->Q: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 93 V H b 6.0 7v61_B NAG:NDG beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. 0 0 6 0 0 0 0 30 0 25 0 0 0 0 0 3 0 36 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 94 K H e 27.8 7v61_B 0 0 0 0 0 0 0 0 67 0 14 0 6 0 14 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 95 L H e 27.0 7v61_B TRS:EDO:PEG:PGE 0 0 0 0 0 0 0 0 5 6 0 0 0 0 83 0 6 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 96 Q H b 4.6 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. 0 0 0 7 0 0 0 21 0 6 10 0 0 57 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 97 L H b 0.0 7v61_B SPIKE_SARS2:Spike glycoprotein[1048 aa] 8 0 0 0 18 0 0 25 0 49 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 98 Q H e 45.9 7v61_B GOL 0 0 0 8 0 19 0 0 38 0 0 0 0 16 12 7 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 99 A H e 36.6 7v61_B BNP_GLOBL:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Peptide 1[13 aa]:Peptide 2[15 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] 3ES ZN 34 0 0 0 0 0 8 0 33 0 0 0 0 0 0 11 0 0 0 14 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 100 L H b 4.5 7v61_B Peptide 1[13 aa]:Cyclic peptide 2[15 aa] ZN 0 0 0 0 0 0 0 15 0 52 0 0 0 0 0 0 0 33 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 101 Q H b 17.9 7v61_B SPIKE_SARS2:Spike glycoprotein[1048 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. PEG:EDO 0 0 0 0 0 0 0 0 0 0 0 0 0 54 6 28 12 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 102 Q e 55.6 7v61_B BNP_GLOBL:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Bradykinin potentiating peptide b[11 aa]:Peptide 1[13 aa]:Peptide 2[15 aa]:Cyclic peptide 2[15 aa] FT8:NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa]:Processed angiotensin-converting enzyme 2[596 aa] ACT:EDO:BO3:GOL 0 0 17 0 14 0 4 0 20 0 0 16 0 19 0 0 11 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 103 N e 42.4 7v61_B Bradykinin potentiating peptide b[11 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR.. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. EPE:EDO:PG4 0 0 0 14 0 0 0 13 0 38 3 6 0 0 0 17 6 3 0 0 CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 104 G G b 17.9 7v61_B BNP_GLOBL:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Bradykinin potentiating peptide b[11 aa]:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR.. 3ES:FT8 EPE:ACT:PEG:EDO:BO3 0 0 16 7 0 74 0 0 0 0 0 0 0 3 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 105 S G e 34.4 7v61_B BNP_GLOBL:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Bradykinin potentiating peptide b[11 aa]:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR.. 3ES:FT8:NAG EPE:ACT:SO4:PEG:IMD:EDO:BO3 8 0 0 0 0 0 0 0 7 0 14 0 11 0 19 19 10 0 0 12 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 106 S G e 49.2 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa]:Processed angiotensin-converting enzyme 2[596 aa] PG4 37 0 0 0 0 0 0 0 0 0 0 0 0 0 0 63 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 107 V G e 32.0 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa] EDO:PG4 57 0 0 0 0 0 0 0 0 0 0 11 0 0 0 7 0 25 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 108 L S b 15.7 7v61_B ACE2_HUMAN:Processed angiotensin-converting enzyme 2[596 aa] PG4 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 109 S e 47.7 7v61_B PG4 14 0 6 0 0 0 0 0 0 0 0 8 43 0 0 29 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 110 E H e 67.8 7v61_B ACE2_HUMAN:Processed angiotensin-converting enzyme 2[596 aa] PG4 30 0 7 12 4 0 0 0 0 11 0 0 27 0 0 0 7 3 0 0 MUTAGEN:/note="E->P: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="E->P: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 111 D H e 68.5 7v61_B EDO 0 0 38 28 0 0 0 0 13 0 0 3 0 3 0 14 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 112 K H e 38.2 7v61_B 0 0 33 19 0 0 0 0 34 0 0 0 0 0 14 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 113 S H b 19.5 7v61_B EPE:PG4 0 0 0 0 21 0 0 0 0 26 0 7 0 0 11 16 0 0 0 20 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 114 K H e 59.0 7v61_B EDO 26 0 0 19 0 0 0 0 17 14 0 0 0 24 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 115 R H e 39.1 7v61_B NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 8 0 14 38 0 0 0 0 12 0 0 0 0 12 16 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 116 L H b 1.7 7v61_B FT8 PEG 0 0 0 0 0 0 0 0 0 42 7 0 0 0 0 0 0 0 0 51 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 117 N H e 46.7 7v61_B ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:Cyclic peptide 2[15 aa] ACT 0 0 0 0 0 0 0 0 0 12 0 60 0 8 0 21 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 118 T H e 45.5 7v61_B NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. ACT:BO3:EDO 0 0 6 6 0 7 0 0 3 0 0 8 0 30 7 6 28 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 119 I H b 0.0 7v61_B NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 22 0 0 0 0 0 0 48 0 19 0 0 0 0 0 0 6 6 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 120 L H b 18.5 7v61_B Bradykinin potentiating peptide b[11 aa]:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:Cyclic peptide 2[15 aa] FT8 ACT 0 0 0 0 0 0 0 8 0 71 0 7 0 14 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 121 N H e 63.0 7v61_B ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 2[15 aa]:Cyclic peptide 2[15 aa] PGE:ACT:PEG:EDO 14 0 0 0 0 0 0 0 0 16 3 23 0 0 0 37 7 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 122 T H e 33.1 7v61_B NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. PGE:ACT:PEG:EDO:BO3 32 0 31 0 0 0 0 0 4 0 0 6 0 0 0 8 13 0 0 7 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 123 M H b 0.0 7v61_B 0 0 0 0 0 0 0 0 0 21 79 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 124 S H e 25.0 7v61_B ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 2[15 aa]:Cyclic peptide 2[15 aa] FT8 ACT 0 0 5 38 0 0 0 0 0 0 0 14 0 8 0 28 7 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 125 T H e 45.5 7v61_B ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR.. NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. EDO:PEG:PGE 0 0 0 0 0 0 0 0 12 0 0 0 0 0 20 12 57 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 126 I H b 14.6 7v61_B NAG ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] EDO:PEG 10 0 14 0 0 0 0 44 0 0 0 20 0 0 0 0 13 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 127 Y H b 12.6 7v61_B ACT:BO3 0 0 0 0 12 0 0 0 0 0 0 0 0 0 0 14 0 0 0 74 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 128 S H e 57.8 7v61_B ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR.. 20 0 0 0 0 0 0 0 14 0 0 7 0 0 0 60 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 129 T H e 53.2 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] PEG:EDO 0 0 14 0 0 0 0 3 12 3 0 0 0 0 7 0 48 13 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 130 G e 21.4 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[749 aa] EDO 48 0 0 0 0 23 0 0 0 0 0 0 0 0 0 17 0 12 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 131 K E e 52.4 7v61_B EDO 0 0 0 7 0 0 0 0 46 0 0 13 0 0 6 4 25 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 132 V E b 0.7 7v61_B 6 0 0 0 0 0 0 17 0 0 0 0 0 0 0 0 0 76 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 133 C E e 36.7 7v61_B EDO 0 96 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 DISULFID:ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 134 N e 24.8 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. ACT 0 0 30 0 6 0 7 0 0 7 0 26 0 0 4 8 0 0 0 9 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 135 P S e 35.7 7v61_B disordered segment of collectrin homology domain[2.. 4 0 7 0 0 0 0 0 14 8 0 0 35 0 0 3 6 3 0 20 MUTAGEN:/note="PD->SM: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="PD->SM: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 136 D S e 82.1 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 0 26 7 0 0 0 0 15 0 3 38 0 0 0 0 8 0 0 0 MUTAGEN:/note="PD->SM: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="PD->SM: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 137 N e 40.0 7v61_B 0 0 12 0 0 22 0 0 6 0 0 42 0 0 0 4 0 14 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 138 P T e 58.1 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 2 0 1 2 1 2 1 1 1 2 1 1 48 1 9 13 11 2 0 1 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 139 Q T e 80.1 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 13 1 1 2 1 7 1 1 1 2 1 1 16 24 1 16 7 2 0 1 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 140 E e 45.2 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 1 0 8 23 0 0 0 0 19 1 0 0 20 0 0 7 19 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 141 C E e 28.0 7v61_B EDO 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISULFID:ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 142 L E e 28.7 7v61_B BR EDO:GOL 14 0 0 0 3 0 0 0 0 62 3 0 0 0 0 0 0 0 11 7 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 143 L E e 33.7 7v61_B BR EDO 9 0 5 0 0 0 3 0 0 33 0 0 10 10 0 15 14 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 144 L I b 4.5 7v61_B ACT:BO3 0 0 0 0 0 0 0 0 0 86 0 0 0 14 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 145 E I e 76.9 7v61_B LPR:LSW PEG:BO3 0 0 24 62 0 0 0 0 14 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 146 P I e 56.6 7v61_B BR EDO 0 0 0 0 0 0 0 14 0 0 0 0 86 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 147 G I b 11.9 7v61_B BR EDO 0 0 52 17 0 23 8 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 148 L I b 0.0 7v61_B 0 0 0 0 0 0 0 25 0 61 14 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 149 N H e 28.5 7v61_B XX5 0 0 31 12 0 0 0 0 0 0 0 6 0 14 0 12 25 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 150 E H e 62.8 7v61_B PGE:GOL 0 0 19 39 0 0 0 0 0 0 0 28 0 0 0 14 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 151 I H b 10.5 7v61_B ACT 0 0 0 0 0 0 0 70 0 7 3 0 0 0 8 0 0 12 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 152 M H b 0.0 7v61_B 0 0 0 0 14 0 0 18 0 14 54 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 153 A H e 26.8 7v61_B NA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. PGE:EDO 50 0 0 10 0 0 0 0 0 0 0 0 0 0 14 20 6 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 154 N H e 73.3 7v61_B 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. PGE:EDO:GOL 0 0 0 0 0 0 8 0 18 0 0 30 0 0 0 6 38 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 155 S b 14.8 7v61_B NA EDO:PGE 0 0 0 14 0 0 0 0 0 0 0 0 0 0 0 86 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 156 L e 59.0 7v61_B PGE:EDO 0 0 0 0 0 0 0 0 20 6 0 7 0 0 60 0 7 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 157 D e 50.0 7v61_B 0 0 70 0 0 0 0 0 16 0 0 0 0 0 0 14 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 158 Y H b 9.6 7v61_B 14 0 0 0 0 0 6 0 0 7 0 0 14 7 0 0 0 0 0 53 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 159 N H e 40.6 7v61_B disordered segment of collectrin homology domain[2.. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 8 0 3 34 0 0 0 0 12 0 0 23 0 0 0 14 6 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 160 E H e 41.7 7v61_B 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. ACT:GOL 0 0 3 62 0 0 0 0 5 6 0 0 0 0 21 3 0 0 0 0 MUTAGEN:/note="E->R: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="E->R: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 161 R H b 2.8 7v61_B NA EDO:PGE 0 0 0 0 0 0 0 0 0 77 0 0 0 0 23 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 162 L H b 5.6 7v61_B disordered segment of collectrin homology domain[2.. 14 0 0 0 0 0 0 0 6 60 0 0 0 14 0 0 7 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 163 W H b 15.9 7v61_B ACT:EDO 0 0 0 0 0 0 14 0 0 0 0 0 0 0 0 0 0 0 63 23 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 164 A H b 0.0 7v61_B 57 0 0 0 0 0 0 0 0 14 0 0 0 0 0 0 0 10 0 20 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 165 W H b 0.0 7v61_B CL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 166 E H b 6.5 7v61_B alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:beta-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta.. ACT:IMD 0 0 0 37 0 0 0 0 19 0 0 0 0 7 14 0 9 14 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 167 S H b 10.9 7v61_B EDO 0 0 0 14 0 47 0 0 0 0 0 0 0 6 0 33 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 168 W H b 0.4 7v61_B 0 0 0 0 12 0 0 0 0 0 0 0 0 0 0 0 0 0 74 14 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 169 R H b 4.3 7v61_B CL:BR EDO 0 0 0 0 0 0 19 0 0 0 0 0 0 0 55 0 0 14 0 12 BINDING:/ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774":MUTAGEN:/note="R->Q: About 95% loss of angiotensin I cleavage.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":BINDING:/ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774":MUTAGEN:/note="R->Q: About 95% loss of angiotensin I cleavage.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 170 S H b 16.4 7v61_B beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. ACT:IMD 17 0 52 0 0 0 0 0 0 0 0 11 0 0 0 6 14 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 171 E H e 43.2 7v61_B EDO 38 0 0 23 0 0 0 0 39 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 172 V H b 2.7 7v61_B 26 0 0 0 0 0 0 14 0 0 0 0 0 0 0 14 0 46 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 173 G H b 0.0 7v61_B 14 0 0 0 0 86 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 174 K H e 38.7 7v61_B 0 0 0 0 0 0 0 6 44 0 0 5 0 0 26 0 20 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 175 Q H e 48.0 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] EDO 25 0 0 0 0 0 7 0 0 0 0 0 25 29 0 14 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 176 L H b 0.0 7v61_B 1 0 1 1 1 1 0 20 1 42 15 1 1 1 1 1 7 7 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 177 R H b 5.9 7v61_B ACT:EDO 0 0 0 0 0 0 0 0 20 19 0 0 7 0 54 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 178 P H e 58.9 7v61_B EDO:BO3 5 0 7 0 0 0 0 0 0 0 0 0 65 11 0 12 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 179 L H b 15.7 7v61_B NAG 0 0 0 0 9 0 0 0 12 32 0 14 0 6 0 14 0 7 0 7 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 180 Y H b 0.4 7v61_B 0 0 0 0 42 0 0 0 0 0 0 0 0 0 0 0 0 0 0 58 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 181 E H b 19.6 7v61_B EDO:PEG:BO3:ACT 8 0 7 41 0 0 0 0 0 0 0 14 19 11 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 182 E H e 34.7 7v61_B NA BO3:ACT 0 0 12 43 0 0 0 0 25 0 0 14 0 0 6 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 183 Y H b 0.0 7v61_B 0 0 0 0 17 0 0 14 0 0 0 0 0 0 0 0 0 0 0 68 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 184 V H b 6.0 7v61_B EDO:PEG 0 0 0 0 0 0 0 14 0 0 0 0 0 0 0 0 6 80 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 185 V H e 52.7 7v61_B EDO:PEG 12 0 3 28 0 0 0 0 0 0 0 0 0 7 14 0 19 17 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 186 L H b 6.2 7v61_B 0 0 0 0 10 0 0 14 0 76 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 187 K H b 8.0 7v61_B EPE:SO4:PEG 0 0 0 4 0 0 0 3 19 7 0 12 0 0 0 41 15 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 188 N H b 10.3 7v61_B PEG:EDO 0 0 0 0 0 0 0 0 0 0 0 80 0 0 8 0 12 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 189 E H e 28.6 7v61_B ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa]:Processed angiotensin-converting enzyme 2[596 aa] 0 0 0 48 0 0 0 0 49 0 0 0 0 3 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 190 M H b 1.9 7v61_B ACT:EDO:BO3 48 0 0 0 0 14 0 9 0 0 23 0 0 0 0 6 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 191 A H b 0.0 7v61_B Bradykinin potentiating peptide b[11 aa] ACT:EDO:BO3 81 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 11 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 192 R H e 54.2 7v61_B ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa]:Processed angiotensin-converting enzyme 2[596 aa] ACT 0 0 0 0 0 0 3 0 38 0 0 7 0 20 33 0 0 0 0 0 MUTAGEN:/note="R->D: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="R->D: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 193 A T e 41.1 7v61_B NAG beta-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(.. ACE2_HUMAN:Processed angiotensin-converting enzyme 2[596 aa] EDO:ACT 23 0 0 0 0 0 0 7 0 53 5 0 0 6 0 0 0 0 0 7 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 194 N T b 15.8 7v61_B NAG CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa]:Processed angiotensin-converting enzyme 2[596 aa] ACT:PEG:EDO:BO3 0 0 11 0 0 0 0 0 0 0 0 89 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 195 H T e 91.1 7v61_B NAG CL beta-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa]:Processed angiotensin-converting enzyme 2[596 aa] PEG:EDO:ACT:GOL 0 0 0 0 0 66 6 0 0 0 0 28 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 196 Y e 24.3 7v61_B Peptide 2[15 aa]:Cyclic peptide 2[15 aa] CL ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa]:Processed angiotensin-converting enzyme 2[596 aa] ACT:PEG:EDO:BO3:GOL 0 0 0 0 37 0 8 0 0 0 0 0 0 0 0 0 0 0 0 55 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 197 E S e 64.3 7v61_B ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa]:Processed angiotensin-converting enzyme 2[596 aa] PGE 17 0 0 35 0 0 0 0 7 0 0 3 0 0 8 9 15 7 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 198 D S b 2.5 7v61_B 0 0 72 0 0 0 0 0 0 0 0 14 0 0 0 14 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 199 Y H b 3.9 7v61_B 13 0 0 0 0 32 0 0 0 0 7 7 0 0 0 0 11 0 0 31 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 200 G H b 0.0 7v61_B MLA 20 0 0 0 0 80 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 201 D H b 2.5 7v61_B ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa]:Processed angiotensin-converting enzyme 2[596 aa] PEG:PGE 26 0 57 12 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 202 Y H e 26.1 7v61_B Bradykinin potentiating peptide b[11 aa]:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 1[13 aa]:Peptide 2[15 aa]:Cyclic peptide 2[15 aa] FT8 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. ACT:SO4:EDO:BO3:GOL 9 0 0 0 0 0 0 0 0 7 14 0 0 0 0 16 0 6 0 48 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 203 W H b 11.2 7v61_B 3ES:MLA:FT8 EPE:SO4:PEG:GOL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 204 R G b 1.6 7v61_B MLA ACT:PEG:PGE:BO3:EDO 0 0 0 0 0 0 0 0 0 12 0 0 0 0 80 0 0 8 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 205 G G e 28.6 7v61_B GOL 4 0 12 0 0 23 0 0 0 0 0 0 0 8 0 54 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 206 D G e 37.0 7v61_B Peptide 6[12 aa]:Cyclic peptide 2[15 aa] 3ES:FT8 CL PEG:TRS:EDO:PGE:ACT:GOL 18 0 23 12 8 0 0 0 7 3 7 0 0 0 0 6 0 0 17 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 207 Y S b 0.0 7v61_B CL 0 0 0 0 14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 86 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 208 E e 28.6 7v61_B ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa] TRS:GOL 0 0 25 75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 209 V B b 7.3 7v61_B PEG:EDO:PGE:BO3:ACT 9 1 2 8 1 2 1 2 2 3 18 1 2 1 2 23 8 12 0 1 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 210 N e 62.4 7v61_B ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa]:Processed angiotensin-converting enzyme 2[596 aa] PEG:PGE:BO3:EDO:ACT 2 1 14 15 1 2 1 2 5 3 1 8 12 1 2 16 11 2 0 1 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 211 G e 51.2 7v61_B alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa] PGE:EDO 2 1 5 2 5 19 1 2 2 3 1 4 2 1 2 23 17 2 7 1 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 212 V S b 14.7 7v61_B alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. PEG:PGE:BO3:EDO:ACT 10 1 2 3 7 3 1 2 3 30 1 2 2 2 2 3 9 13 1 1 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 213 D S e 92.6 7v61_B alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. ACT:EDO:PGE:BO3 4 1 15 38 2 10 1 2 3 4 1 2 2 2 2 3 3 3 1 1 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 214 G S e 67.9 7v61_B alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. EDO 4 1 15 3 2 20 1 3 17 5 1 2 3 2 3 7 3 4 1 2 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 215 Y e 21.7 7v61_B alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. EDO 4 1 3 3 2 4 1 3 3 5 1 2 11 2 3 4 3 18 1 25 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 216 D e 48.1 7v61_B NAG NA alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. EDO 4 1 26 3 2 4 15 3 3 4 1 15 3 2 3 4 3 3 1 2 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 217 Y B b 3.5 7v61_B NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. EDO 4 1 8 3 10 4 1 3 17 4 1 2 3 2 3 4 3 3 1 24 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 218 S e 51.6 7v61_B NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa] 18 1 3 11 2 4 1 3 3 4 1 9 3 2 3 20 9 3 1 2 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 219 R S b 18.2 7v61_B CL ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa]:Processed angiotensin-converting enzyme 2[596 aa] PEG:GOL 2 1 7 16 7 2 1 2 2 3 1 1 2 1 32 14 2 2 0 1 MUTAGEN:/note="R->D: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="R->D: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 220 G S e 42.9 7v61_B ACE2_HUMAN:Processed angiotensin-converting enzyme 2[591 aa] 9 1 6 8 16 9 1 2 2 4 1 11 14 2 2 6 2 3 1 1 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 221 Q H e 40.3 7v61_B NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. 3 1 16 2 2 3 1 2 2 4 1 2 2 30 2 3 20 3 1 1 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 222 L H b 0.6 7v61_B 3 1 2 2 20 3 1 2 2 41 1 2 2 7 2 3 2 3 1 1 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 223 I H b 19.3 7v61_B BR 3 1 2 8 2 3 1 21 2 9 5 16 2 2 9 3 8 3 1 1 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 224 E H e 67.8 7v61_B 1 0 11 31 0 1 0 0 28 1 0 0 0 23 0 1 0 1 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 225 D H b 15.4 7v61_B PEG:EDO 0 0 69 4 0 0 0 0 0 0 0 0 0 28 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 226 V H b 0.7 7v61_B 0 7 0 0 0 0 0 20 0 51 0 0 0 0 0 0 0 23 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 227 E H e 35.2 7v61_B EDO 0 0 22 72 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 228 H H e 59.7 7v61_B EDO:PEG 14 0 10 0 0 0 15 0 21 1 0 4 0 14 19 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 229 T H b 3.2 7v61_B PEG 0 0 0 0 0 0 0 20 0 44 0 0 0 0 0 0 31 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 230 F H b 3.3 7v61_B 0 0 0 0 53 0 0 0 0 0 0 0 0 0 0 0 0 0 7 41 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 231 E T e 59.8 7v61_B EDO 13 0 0 15 0 0 0 0 18 0 0 5 0 32 0 14 3 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 232 E T e 31.7 7v61_B CL 0 0 12 49 0 0 0 0 0 0 0 0 0 25 0 0 14 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 233 I T b 0.0 7v61_B 0 0 0 0 0 0 0 55 0 45 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 234 K H e 36.8 7v61_B GOL:EDO 0 0 0 11 0 0 0 0 35 8 0 0 0 40 6 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 235 P H e 48.8 7v61_B EDO 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 236 L H b 3.9 7v61_B EDO 0 0 0 0 29 0 0 0 0 71 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 237 Y H b 0.4 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 238 E H e 30.7 7v61_B GOL:EDO 0 0 6 23 0 0 0 0 0 37 0 0 0 26 8 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 239 H H b 17.3 7v61_B EDO 0 0 0 0 0 0 16 0 0 14 0 37 0 33 0 0 0 0 0 0 MUTAGEN:/note="H->Q: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="H->Q: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 240 L H b 1.1 7v61_B 0 0 0 0 0 0 0 6 0 88 0 0 0 0 0 0 0 6 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 241 H H b 0.0 7v61_B 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 242 A H b 0.0 7v61_B 80 0 0 0 0 20 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 243 Y H b 3.0 7v61_B 2PE:XPE P6G:PE4:PEG:PG4:IMD:PGE:EDO:ACT 0 0 0 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 95 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 244 V H b 0.0 7v61_B 0 0 0 0 0 0 0 0 0 0 14 0 0 0 0 0 0 86 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 245 R H b 1.2 7v61_B 0 0 0 0 0 3 0 0 0 0 0 0 0 0 97 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 246 A H e 27.7 7v61_B 2PE:XPE P6G:PE4:PEG:EDO:PG4:PGE:ACT 16 0 0 0 14 0 0 0 0 0 0 0 0 0 61 0 3 0 0 6 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 247 K H e 27.4 7v61_B XPE P6G:PE4:PEG:PG4:PGE:EDO:GOL 16 0 0 0 0 0 0 0 35 0 0 0 0 14 20 16 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 248 L H b 0.0 7v61_B 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 249 M T e 28.0 7v61_B PGE:ACT:EDO 14 0 0 0 0 0 25 3 0 0 20 6 0 7 14 0 0 0 0 12 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 250 N T e 77.6 7v61_B 2PE:XPE P6G:PE4:PEG:PG4:EDO:PGE:ACT 0 0 15 3 0 14 7 0 18 0 0 6 0 8 28 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 251 A T e 37.5 7v61_B P6G:PEG:EDO 6 0 0 0 6 0 33 14 7 0 0 0 0 0 11 0 13 3 0 7 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 252 Y S b 4.3 7v61_B NA EDO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 253 P T e 62.8 7v61_B PGE:ACT 0 0 12 0 0 22 0 0 0 0 0 0 67 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 254 S T e 96.1 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[593 aa] EDO:GOL 12 0 14 16 0 0 0 0 5 0 0 0 0 7 0 32 0 14 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 255 Y T e 39.6 7v61_B EDO 0 0 0 0 0 14 13 7 0 7 0 0 0 0 6 0 0 20 0 34 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 256 I S b 6.4 7v61_B GOL 7 0 0 0 0 0 0 60 0 14 8 0 0 0 0 0 0 12 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 257 S b 18.0 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[593 aa] GOL 0 0 7 0 7 0 0 0 0 0 0 30 8 0 0 49 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 258 P T e 53.5 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[593 aa] EDO:PGE 8 0 0 6 0 0 0 0 20 37 0 0 26 0 3 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 259 I T e 52.0 7v61_B 0 0 23 18 0 0 0 6 12 0 0 0 0 0 12 0 28 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 260 G S b 0.0 7v61_B 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 261 C b 0.0 7v61_B 0 23 0 0 0 0 7 0 0 0 0 8 63 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 262 L E b 0.0 7v61_B 0 0 0 0 0 0 0 71 0 29 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 263 P E b 0.0 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 264 A T b 4.5 7v61_B 80 0 0 0 0 0 0 8 0 0 12 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 265 H T b 0.0 7v61_B 0 0 0 0 0 0 92 0 0 0 0 0 0 0 0 8 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 266 L S b 0.0 7v61_B EDO 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 267 L S b 1.7 7v61_B 0 0 0 0 14 0 0 0 0 86 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 268 G S b 2.4 7v61_B 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 269 D S b 14.8 7v61_B GOL:SO4 0 0 23 0 0 0 0 0 0 0 0 63 0 0 0 14 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 270 M S b 0.0 7v61_B 0 0 0 0 0 0 0 0 0 14 86 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 271 W S b 13.9 7v61_B CL GOL:ACT:EDO:PEG:BO3 0 0 14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 86 0 MUTAGEN:/note="W->Q: About 95% loss of angiotensin I cleavage.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="W->Q: About 95% loss of angiotensin I cleavage.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 272 G b 6.0 7v61_B 55 0 0 0 0 45 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 273 R S b 14.2 7v61_B ANGT_HUMAN:BNP_GLOBL:KNG1_HUMA:A4_HUMAN:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:BRADYKININ[4 aa]:BETA-AMYLOID PROTEIN 42[3 aa]:AMYLOID BETA A4 PROTEIN[2 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ILE-PRO-PRO[3 aa]:VAL-PRO-PRO[3 aa] LPR:X8Z:NXA:XX5:EAL:MCO:RX3:X92:X93:X94:X95:RX4:3ES:SLC:KAF:KAW:LSW:1IU:9X6:3EF:ASP:PRO:MLT:LYS:VAL:SER:NIY:BJ2:D0W:D0Z:FT8:KSN:KS8:BCN:8KC:8J9:8JV ZN:CL ACT:FLC:EPE:GOL:SO4:EDO 0 0 0 0 0 14 0 0 0 0 0 0 0 63 23 0 0 0 0 0 BINDING:/ligand="substrate":MUTAGEN:/note="R->Q: Complete loss of enzyme activity. Does not affect amino acid transport activity of SLC6A19." ECO:0000269|PubMed:19185582":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":BINDING:/ligand="substrate":MUTAGEN:/note="R->Q: Complete loss of enzyme activity. Does not affect amino acid transport activity of SLC6A19." ECO:0000269|PubMed:19185582":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 274 F e 28.2 7v61_B ANGT_HUMAN:ANGIOTENSIN-2[8 aa] RX3:3EF:3ES:LYS:NIY:8KC MG:NA:CA EPE:GOL:SO4:EDO 0 0 14 0 23 0 0 0 0 0 0 0 0 17 0 27 19 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 275 W b 0.8 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 276 T G e 31.2 7v61_B NA:CA:MG PE4:SO4:1PE:P6G:EDO 0 0 0 12 0 0 0 0 0 0 0 20 0 0 0 45 23 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 277 N G e 44.2 7v61_B NA:CA:MG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. PE4:PGE:EDO:1PE 14 0 0 14 0 0 0 0 0 0 0 66 0 0 0 6 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 278 L G b 3.4 7v61_B EDO:PGE 0 0 0 0 0 0 14 55 0 31 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 279 Y H b 16.1 7v61_B PE4:ACT:PEG:1PE:BO3:P6G:EDO:PGE 12 0 0 7 0 0 0 0 0 14 0 0 0 0 0 0 0 0 0 67 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 280 S H e 75.0 7v61_B NA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. EDO:PGE:GOL 0 0 56 14 0 0 0 0 0 0 0 0 13 0 0 10 0 0 0 7 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 281 L H e 21.3 7v61_B XPE NA P6G:PE4:PEG:PGE:EDO:GOL 0 0 0 0 0 0 0 12 0 69 0 0 0 14 0 0 6 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 282 T H b 0.0 7v61_B 2PE:XPE P6G:PE4:PEG:PG4:PGE:EDO:GOL 0 0 0 0 8 0 0 0 0 7 5 0 0 0 0 0 37 43 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 283 V e 24.0 7v61_B 2PE:XPE P6G:PE4:PEG:PG4:IMD:PGE:EDO:ACT:GOL 13 0 0 0 0 0 0 0 14 7 0 0 0 0 7 12 11 37 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 284 P S b 17.1 7v61_B XPE P6G:PE4:PEG:PG4:IMD:EDO:ACT 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 285 F S b 18.7 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. PEG:EDO 7 0 0 0 74 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 286 G T e 65.5 7v61_B PE4 3 0 0 18 0 13 0 0 0 3 0 0 63 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 287 Q T e 73.5 7v61_B 0 0 17 34 0 0 4 0 0 0 0 0 0 19 0 19 7 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 288 K S e 29.2 7v61_B 19 0 0 14 0 0 0 0 60 7 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 289 P e 83.7 7v61_B 7 0 0 0 0 0 0 0 0 0 0 0 72 0 0 21 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 290 N e 33.3 7v61_B CL PE4:ACT:1PE:BO3:EDO:PEG 1 0 1 1 8 1 0 1 4 13 0 37 7 1 1 18 4 1 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 291 I b 16.4 7v61_B GOL 1 0 1 7 1 1 0 30 1 15 17 1 1 1 1 1 1 20 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 292 D e 57.4 7v61_B P6G:EDO:PEG 0 0 86 14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 293 V b 2.7 7v61_B 16 0 0 0 0 0 0 13 0 0 0 0 0 0 0 0 17 53 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 294 T T b 18.2 7v61_B P6G:1PE 0 0 0 0 0 0 0 0 8 0 0 0 14 0 0 15 63 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 295 D T e 67.9 7v61_B NAG EDO:PEG 20 0 31 44 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 296 A H e 28.6 7v61_B NAG TRS 53 0 0 26 0 0 0 7 4 0 0 0 0 0 0 0 5 6 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 297 M H b 0.0 7v61_B 0 0 0 0 0 0 0 0 0 7 93 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 298 V H e 60.0 7v61_B PEG:EDO 0 0 0 17 0 0 0 16 7 17 3 0 0 0 0 0 0 39 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 299 D H e 87.0 7v61_B NAG PEG:EDO 6 0 6 0 0 0 0 7 36 0 0 25 0 6 0 14 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 300 Q T e 38.8 7v61_B PE3:XPE:PE8:NAG:12P alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. PG4:P6G:PE4:EDO:P33:PGE:MXE 0 0 0 0 0 0 0 0 6 0 0 0 0 94 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 301 A T e 70.5 7v61_B PE3:XPE:PE8:12P 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. PG4:P6G:PE4:PEG:EDO:P33:PGE:MXE 6 0 0 0 0 53 7 0 0 0 0 24 0 0 0 10 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 302 W b 2.0 7v61_B PE3:XPE:PE8:12P alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. PG4:P6G:PE4:EDO:P33:PGE:MXE:1PE 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 60 40 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 303 D e 58.6 7v61_B NAG alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. PEG:EDO:PGE 0 0 23 0 0 0 0 0 0 0 0 11 0 0 7 0 60 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 304 A T b 10.7 7v61_B A0A1W6ASU7_9NIDO:Spike glycoprotein[192 aa] 40 0 0 0 0 0 0 0 0 0 0 0 38 0 0 0 14 8 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 305 Q T e 39.3 7v61_B U5NJG5_MERS:A0A1W6ASU7_9NIDO:Spike glycoprotein[187 aa]:Spike glycoprotein[192 aa] NAG:PE3 alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. EDO:PGE:ACT 0 0 0 17 0 0 0 0 14 18 0 0 0 18 22 0 11 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 306 R H e 36.0 7v61_B NAG:PE3:XPE:PE8:12P alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. PG4:P6G:PE4:PEG:P33:EDO:PGE:MXE:1PE 0 0 0 0 0 0 11 0 47 0 0 0 0 0 42 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 307 I H b 1.2 7v61_B 0 0 0 0 0 0 0 32 0 14 53 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 308 F H b 0.0 7v61_B A0A1W6ASU7_9NIDO:Spike glycoprotein[192 aa] 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 309 K H e 46.2 7v61_B NAG:PE3:XPE:PE8:12P CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. P6G:PEG:EDO:PGE:MXE:P33:ACT:1PE 0 0 0 18 0 0 0 0 36 0 0 0 0 21 11 0 0 14 0 0 MUTAGEN:/note="K->D: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="K->D: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 310 E H b 13.6 7v61_B PE3:XPE:PE8:NAG:12P P6G:PEG:P33:PG4:PGE:MXE:1PE 0 0 0 49 0 0 0 0 0 14 12 0 0 0 0 0 14 11 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 311 A H b 0.0 7v61_B 69 0 0 0 0 20 0 0 0 0 0 0 0 0 0 12 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 312 E H b 10.6 7v61_B NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. EDO:ACT 0 0 46 34 0 0 0 0 0 0 0 7 0 0 0 0 0 0 0 14 MUTAGEN:/note="E->A: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="E->A: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 313 K H e 53.3 7v61_B PE3:XPE:PE8:NAG:12P 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. P6G:PEG:P33:PGE:MXE:GOL:1PE 0 0 18 11 0 0 0 0 26 7 0 10 0 8 14 0 7 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 314 F H b 2.9 7v61_B NAG GOL 0 0 0 0 86 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 315 F H b 0.5 7v61_B 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 316 V H e 40.0 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. PE4:EDO:ACT 0 0 0 0 0 0 0 3 21 0 0 0 0 14 0 0 39 23 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 317 S T b 19.5 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 318 V T b 2.7 7v61_B 14 0 0 0 0 0 0 4 0 45 18 0 0 0 0 0 0 19 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 319 G T e 48.8 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. PE4:EDO:GOL 0 0 0 0 0 91 0 0 0 0 0 6 0 0 0 4 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 320 L b 3.4 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. EDO 0 0 0 0 14 0 0 0 0 71 14 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 321 P e 52.7 7v61_B SPIKE_CVHNL:Spike glycoprotein[110 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. EDO:PEG 0 0 0 0 0 0 0 7 6 37 0 0 37 0 8 0 6 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 322 N e 62.4 7v61_B SPIKE_CVHNL:Spike glycoprotein[110 aa]:Spike protein S1[131 aa] NAG:NDG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. EDO 8 0 0 5 0 0 17 0 12 0 0 13 32 10 0 0 0 0 0 4 CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 323 M b 7.2 7v61_B SPIKE_CVHNL:SPIKE_SARS2:Spike glycoprotein[110 aa]:Spike protein S1[131 aa]:Spike glycoprotein[1048 aa] NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. EDO 7 0 0 0 0 0 0 0 0 34 40 0 0 0 0 0 0 19 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 324 T e 35.7 7v61_B SPIKE_CVHNL:SPIKE_SARS2:SPIKE_SARS:Spike glycoprotein[110 aa]:Spike protein S1[131 aa]:Spike protein S1[194 aa]:Spike glycoprotein[981 aa]:Spike protein S1[203 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1038 aa]:Spike protein S1[195 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike protein S1[190 aa]:Spike glycoprotein[1062 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1066 aa]:Spike glycoprotein[1097 aa]:Spike glycoprotein[195 aa]:Spike glycoprotein[1011 aa]:Spike glycoprotein[993 aa]:Spike glycoprotein[992 aa]:Spike protein S2' [196 aa] NAG CL 0 0 0 0 0 0 0 0 0 0 0 0 74 0 0 3 23 0 0 0 MUTAGEN:/note="T->A: No effect on interaction with SARS-CoV spike glycoprotein.":MUTAGEN:/note="T->P: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="T->A: No effect on interaction with SARS-CoV spike glycoprotein.":MUTAGEN:/note="T->P: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 325 Q S e 76.0 7v61_B SPIKE_CVHSA:SPIKE_CVHNL:SPIKE_SARS2:SPIKE_SARS:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[110 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[131 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[1030 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike protein S1[187 aa]:Spike protein S1[184 aa]:Spike protein S1[185 aa]:Spike protein S1[190 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[194 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1032 aa]:Spike protein S1[186 aa]:Spike glycoprotein[1048 aa]:Spike protein S1[195 aa]:Spike glycoprotein[1062 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1042 aa]:Spike protein S1[194 aa]:Spike protein S1[192 aa]:Spike glycoprotein[993 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. BO3 0 0 0 3 0 0 0 0 14 0 0 0 45 38 0 0 0 0 0 0 MUTAGEN:/note="Q->P: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="Q->P: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 326 G S e 31.0 7v61_B SPIKE_CVHNL:SPIKE_CVHSA:SPIKE_SARS2:SPIKE_SARS:Spike glycoprotein[110 aa]:Spike glycoprotein[1057 aa]:Spike protein S1[195 aa]:Spike protein S1[131 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1032 aa]:Spike protein S1[186 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1066 aa]:Spike glycoprotein[1011 aa] BO3 7 0 6 36 0 20 0 0 0 0 0 0 7 0 3 22 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 327 F T b 0.0 7v61_B U5NJG5_MERS:SPIKE_SARS2:Spike glycoprotein[187 aa]:Spike glycoprotein[195 aa] 0 0 0 0 86 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 328 W T e 21.1 7v61_B U5NJG5_MERS:A0A1W6ASU7_9NIDO:Spike glycoprotein[187 aa]:Spike glycoprotein[192 aa] PE3:NAG CL alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. EDO:ACT 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 329 E T e 63.3 7v61_B SPIKE_CVHSA:D9IEJ2_BPT4:SPIKE_SARS2:U5NJG5_MERS:A0A1W6ASU7_9NIDO:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike protein S1[188 aa]:Spike glycoprotein[187 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1062 aa]:Spike glycoprotein[1011 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. EDO:BO3:PG4 9 0 15 24 0 0 0 7 0 0 0 27 0 0 0 0 18 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 330 N S e 45.5 7v61_B SPIKE_CVHSA:SPIKE_CVHNL:D9IEJ2_BPT4:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:SPIKE_SARS:A0A6B9WHD3_SARS:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:U5NJG5_MERS:A0A1W6ASU7_9NIDO:WAC_BPT4:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[110 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[195 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1016 aa]:Spike glycoprotein[1008 aa]:Spike glycoprotein[194 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[131 aa]:Spike protein S1[192 aa]:Spike glycoprotein[997 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1029 aa]:Spike glycoprotein[1030 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[188 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[196 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike glycoprotein[187 aa]:Spike protein S1[186 aa]:Spike protein S1[190 aa]:RshSTT182/200 coronavirus receptor binding domain ..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1097 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:Spike glycoprotein[1045 aa]:Spike protein S2' [167 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1011 aa]:Spike glycoprotein[185 aa]:PRD-0038[174 aa]:Spike glycoprotein[1047 aa]:Spike glycoprotein[991 aa] EDO:PG4 0 0 0 6 0 0 0 0 49 8 0 23 0 0 0 14 0 0 0 0 MUTAGEN:/note="N->Y: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein. In sACE2.v2.2; increases interaction with RBD domain of SARS-CoV-2 spike protein; when associated with Y-27 and L-386.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="N->Y: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein. In sACE2.v2.2; increases interaction with RBD domain of SARS-CoV-2 spike protein; when associated with Y-27 and L-386.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 331 S e 20.3 7v61_B U5NJG5_MERS:A0A1W6ASU7_9NIDO:Spike glycoprotein[187 aa]:Spike glycoprotein[192 aa] EDO:BO3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 332 M B b 19.8 7v61_B U5NJG5_MERS:A0A1W6ASU7_9NIDO:Spike glycoprotein[187 aa]:Spike glycoprotein[192 aa] EDO:BO3 0 0 0 0 0 0 0 26 0 0 66 0 0 0 0 0 0 8 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 333 L b 6.2 7v61_B U5NJG5_MERS:A0A1W6ASU7_9NIDO:Spike glycoprotein[187 aa]:Spike glycoprotein[192 aa] EDO 0 0 0 0 14 0 0 12 0 67 7 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 334 T S e 49.4 7v61_B U5NJG5_MERS:A0A1W6ASU7_9NIDO:Spike glycoprotein[187 aa]:Spike glycoprotein[192 aa] NAG EDO 14 0 0 55 0 0 0 0 0 0 0 0 0 0 0 0 31 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 335 D e 46.9 7v61_B U5NJG5_MERS:A0A1W6ASU7_9NIDO:Spike glycoprotein[187 aa]:Spike glycoprotein[192 aa] PGE 0 0 6 17 0 0 0 0 55 0 0 0 0 0 22 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 336 P e 40.3 7v61_B U5NJG5_MERS:A0A1W6ASU7_9NIDO:Spike glycoprotein[187 aa]:Spike glycoprotein[192 aa] PGE:EDO 0 0 0 0 0 0 0 0 0 0 0 0 86 0 0 0 0 14 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 337 G e 70.2 7v61_B PGE 22 0 14 0 0 23 0 0 0 0 0 0 0 0 0 6 22 0 14 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 338 N S e 66.1 7v61_B U5NJG5_MERS:A0A1W6ASU7_9NIDO:Spike glycoprotein[187 aa]:Spike glycoprotein[192 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. 0 0 80 0 0 0 0 0 0 0 0 6 0 0 0 14 0 0 0 0 MUTAGEN:/note="NVQ->DDR: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="NVQ->DDR: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 339 V S e 96.0 7v61_B NAG 2 1 5 2 1 61 1 1 2 3 1 1 1 1 1 5 2 8 0 1 MUTAGEN:/note="NVQ->DDR: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="NVQ->DDR: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 340 Q S e 37.2 7v61_B U5NJG5_MERS:A0A1W6ASU7_9NIDO:Spike glycoprotein[187 aa]:Spike glycoprotein[192 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. EDO:BO3 0 0 0 0 0 0 0 0 14 0 0 0 0 6 80 0 0 0 0 0 MUTAGEN:/note="NVQ->DDR: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="NVQ->DDR: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 341 K e 65.1 7v61_B NAG PGE 0 0 32 37 0 0 8 0 23 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 342 A e 20.5 7v61_B 3 0 0 0 0 0 0 0 0 12 14 0 0 0 0 0 0 71 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 343 V e 48.0 7v61_B ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Cyclic peptide 2[15 aa] 0 0 0 7 0 0 0 14 0 0 0 0 0 0 0 0 0 79 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 344 C e 36.7 7v61_B 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISULFID:ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 345 H e 72.8 7v61_B ANGT_HUMAN:BNP_GLOBL:KNG1_HUMA:A4_HUMAN:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:BRADYKININ[4 aa]:BETA-AMYLOID PROTEIN 42[3 aa]:AMYLOID BETA A4 PROTEIN[2 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:ILE-PRO-PRO[3 aa]:VAL-PRO-PRO[3 aa]:Peptide 2[15 aa]:Cyclic peptide 2[15 aa] LPR:X8Z:NXA:XX5:EAL:MCO:RX3:X92:X93:X94:X95:RX4:K26:3ES:SLC:KAF:KAW:LSW:1IU:3EF:SAC:ASP:LYS:PRO:MLT:GLN:VAL:GLU:SER:NIY:BJ2:D0W:D0Z:FT8:KSN:KS8:BCN:8KC:8J9:8JV ZN:BR alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. ACT:FLC:EPE:SO4:GLY:PEG:EDO:BO3 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="H->A: Complete loss of enzyme activity.":BINDING:/ligand="substrate":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="H->A: Complete loss of enzyme activity.":BINDING:/ligand="substrate":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 346 P e 31.0 7v61_B ANGT_HUMAN:BNP_GLOBL:KNG1_HUMA:A4_HUMAN:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:BRADYKININ[4 aa]:BETA-AMYLOID PROTEIN 42[3 aa]:AMYLOID BETA A4 PROTEIN[2 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:ILE-PRO-PRO[3 aa]:VAL-PRO-PRO[3 aa] LPR:X8Z:XX5:EAL:MCO:RX3:X92:X93:X94:X95:RX4:K26:3ES:SLC:KAF:KAW:LSW:1IU:3EF:SAC:LYS:GLN:GLU:ASP:BJ2:D0W:D0Z:FT8:KSN:KS8:8KC:8J9:8JV ZN:CL:BR alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. ACT:FLC:SO4:GLY:BO3 53 0 0 0 0 0 0 0 0 0 0 0 40 0 0 0 7 0 0 0 BINDING:/ligand="substrate":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":BINDING:/ligand="substrate":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 347 T E e 29.2 7v61_B ANGT_HUMAN:BNP_GLOBL:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:ILE-PRO-PRO[3 aa]:VAL-PRO-PRO[3 aa]:Peptide 2[15 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] LPR:EAL:RX3:X92:X93:X95:RX4:K26:3ES:KAF:KAW:LSW:1IU:3EF:BJ2:D0W:D0Z:FT8:KSN:KS8:BCN:8KC:8J9:8JV alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. FLC:P6G:PEG:EDO:BO3:PGE 14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 63 23 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 348 A E e 24.1 7v61_B ANGT_HUMAN:BNP_GLOBL:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 6[12 aa] RX3:RX4:K26:3ES:KAF:KAW:1IU:3EF:BJ2:D0W:D0Z:BCN:PG0:KS8 alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. EPE:PEG:ACT:FLC:P6G:EDO:PGE:SO4:PG4:1PE:BO3 93 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 349 W E b 17.1 7v61_B BNP_GLOBL:ANGT_HUMAN:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] K26:3ES:KS8:BCN:PG0 EPE:PEG:ACT:P6G:EDO:PGE:PG4:1PE 0 0 0 0 0 0 0 0 0 14 0 0 0 0 0 0 0 0 86 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 350 D E e 28.4 7v61_B ANGT_HUMAN:ANGIOTENSIN-2[8 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 1[13 aa]:Peptide 2[15 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] K26:BCN CL EDO:PGE:PEG:GOL 0 0 93 0 0 0 0 0 0 0 0 7 0 0 0 0 0 0 0 0 MUTAGEN:/note="D->A: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="D->A: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 351 L b 0.0 7v61_B SPIKE_SARS2:Spike glycoprotein[1048 aa]:Spike glycoprotein[954 aa]:Cyclic peptide 2[15 aa]:Spike glycoprotein[1066 aa] PEG:EDO:PG4 0 0 0 0 63 0 0 0 0 23 14 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="L->F: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="L->F: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 352 G S b 4.8 7v61_B ANGT_HUMAN:BNP_GLOBL:SPIKE_SARS2:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1032 aa]:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 1[13 aa]:Peptide 2[15 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] K26:3ES:FT8 CL EPE:EDO:GOL 14 0 0 0 4 23 0 0 0 0 0 17 0 0 0 0 0 0 0 42 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 353 K S e 62.3 7v61_B SPIKE_CVHSA:SPIKE_CVHNL:D9IEJ2_BPT4:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:A0A6B9WHD3_SARS:SPIKE_SARS:M1E1E4_9HIV1:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:WAC_BPT4:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[110 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1080 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[144 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1016 aa]:Spike glycoprotein[1008 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[131 aa]:Spike protein S1[192 aa]:Spike glycoprotein[997 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1030 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1029 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike glycoprotein, Envelope glycoprotein fusion[1..:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[622 aa]:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[196 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1060 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[186 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike glycoprotein[1042 aa]:Spike glycoprotein[1045 aa]:Spike glycoprotein[1097 aa]:Spike glycoprotein[1058 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:Spike protein S1[162 aa]:Spike glycoprotein,Envelope glycoprotein[1061 aa]:Spike glycoprotein[676 aa]:Spike protein S1[167 aa]:Spike protein S2' [167 aa]:Spike protein S2' [181 aa]:Spike protein S2' [183 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1011 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[1005 aa]:Spike glycoprotein[199 aa]:Spike glycoprotein[185 aa]:Spike glycoprotein[962 aa]:Spike glycoprotein[954 aa]:PRD-0038[174 aa]:Spike glycoprotein[1047 aa]:Spike glycoprotein[993 aa]:Spike glycoprotein[992 aa]:Spike glycoprotein[991 aa]:Spike protein S1[172 aa]:Spike protein S2' [196 aa]:Spike glycoprotein,Spike glycoprotein,Spike glycop.. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. EDO:PEG 0 0 0 0 0 0 7 0 23 0 0 19 14 8 17 0 12 0 0 0 MUTAGEN:/note="K->H,A,D: Abolishes interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="K->H,A,D: Abolishes interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 354 G S e 54.8 7v61_B SPIKE_CVHSA:SPIKE_CVHNL:D9IEJ2_BPT4:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:A0A6B9WHD3_SARS:SPIKE_SARS:M1E1E4_9HIV1:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:WAC_BPT4:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[110 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1080 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[144 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[131 aa]:Spike protein S1[192 aa]:Spike glycoprotein[997 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1030 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1029 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike glycoprotein, Envelope glycoprotein fusion[1..:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[622 aa]:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[196 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[186 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike glycoprotein[1042 aa]:Spike glycoprotein[1045 aa]:Spike glycoprotein[1097 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:Spike protein S1[162 aa]:Spike glycoprotein[676 aa]:Spike protein S1[167 aa]:Spike protein S2' [167 aa]:Spike protein S2' [181 aa]:Spike protein S2' [183 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1011 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[1005 aa]:Spike glycoprotein[199 aa]:Spike glycoprotein[185 aa]:Spike glycoprotein[962 aa]:Spike glycoprotein[954 aa]:PRD-0038[174 aa]:Spike glycoprotein[1047 aa]:Spike glycoprotein[993 aa]:Spike glycoprotein[992 aa]:Spike glycoprotein[991 aa]:Spike protein S1[172 aa]:Spike protein S2' [196 aa]:Spike glycoprotein,Spike glycoprotein,Spike glycop.. PG0 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. 0 0 12 0 0 42 0 0 17 0 0 21 0 0 0 8 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 355 D b 9.3 7v61_B SPIKE_CVHSA:SPIKE_CVHNL:D9IEJ2_BPT4:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:A0A6B9WHD3_SARS:SPIKE_SARS:M1E1E4_9HIV1:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:WAC_BPT4:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[110 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[144 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:Spike glycoprotein[1008 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[131 aa]:Spike protein S1[192 aa]:Spike glycoprotein[997 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1030 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1029 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike glycoprotein, Envelope glycoprotein fusion[1..:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[622 aa]:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[196 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1060 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[186 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike glycoprotein[1042 aa]:Spike glycoprotein[1045 aa]:Spike glycoprotein[1097 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:Spike protein S1[162 aa]:Spike glycoprotein[676 aa]:Spike protein S1[167 aa]:Spike protein S2' [167 aa]:Spike protein S2' [181 aa]:Spike protein S2' [183 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1011 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[1005 aa]:Spike glycoprotein[199 aa]:Spike glycoprotein[185 aa]:Spike glycoprotein[962 aa]:Spike glycoprotein[954 aa]:PRD-0038[174 aa]:Spike glycoprotein[1047 aa]:Spike glycoprotein[993 aa]:Spike glycoprotein[992 aa]:Spike glycoprotein[991 aa]:Spike protein S1[172 aa]:Spike protein S2' [196 aa]:Spike glycoprotein,Spike glycoprotein,Spike glycop.. PEG:EDO:PG4 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="D->A: Strongly inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="D->A: Strongly inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 356 F E b 4.8 7v61_B SPIKE_CVHNL:Spike glycoprotein[110 aa]:Spike protein S1[131 aa] EDO 0 0 0 0 80 0 0 0 0 0 0 0 0 0 0 0 0 20 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 357 R E b 5.9 7v61_B SPIKE_CVHSA:SPIKE_CVHNL:D9IEJ2_BPT4:SPIKE_SARS2:A0A6M3G9R1_9BETC:A0A6G6A1M4_9BETC:A0A6B9WHD3_SARS:SPIKE_SARS:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:WAC_BPT4:A0A7D6P0R3_9BETC:SARS-coronavirus spike protein[174 aa]:Spike glycoprotein[173 aa]:Spike glycoprotein[110 aa]:Spike glycoprotein[174 aa]:Spike glycoprotein[1057 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[195 aa]:Spike protein S1[194 aa]:Spike protein S1[183 aa]:SARS-CoV-2 chimeric RBD[193 aa]:SARS-CoV-2 chimeric RBD[194 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1080 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1006 aa]:Spike glycoprotein[1007 aa]:Spike glycoprotein[1068 aa]:Spike glycoprotein[195 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:Spike glycoprotein[1008 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[131 aa]:Spike protein S1[192 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[192 aa]:Spike glycoprotein[1033 aa]:Spike glycoprotein[1030 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1029 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike protein S1[200 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike protein S1[176 aa]:Spike protein S1[182 aa]:Spike glycoprotein[193 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike glycoprotein[250 aa]:Spike glycoprotein[998 aa]:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1032 aa]:Spike glycoprotein[1035 aa]:Spike protein S1[198 aa]:Spike protein S1[188 aa]:Spike protein S1[190 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[1027 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[196 aa]:Spike glycoprotein[1060 aa]:Spike glycoprotein[1098 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1061 aa]:Spike glycoprotein[198 aa]:Spike glycoprotein[197 aa]:Spike protein S1[186 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:Spike glycoprotein[1062 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[1026 aa]:Spike glycoprotein[999 aa]:Spike protein S1[193 aa]:Spike glycoprotein[1066 aa]:Spike glycoprotein[1097 aa]:Spike protein S1[166 aa]:Spike glycoprotein,Fibritin[193 aa]:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:Spike glycoprotein[1045 aa]:Spike glycoprotein[676 aa]:Spike protein S2' [167 aa]:Spike protein S2' [181 aa]:Spike protein S2' [183 aa]:Spike protein S1[199 aa]:Spike glycoprotein[1010 aa]:Spike glycoprotein[1005 aa]:Spike glycoprotein[185 aa]:Spike glycoprotein[954 aa]:PRD-0038[174 aa]:Spike glycoprotein[1047 aa]:Spike protein S1[172 aa]:Spike protein S2' [196 aa] BCN ACT:PEG:EDO:PG4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 MUTAGEN:/note="R->A: Strongly inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="R->A: Strongly inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 358 I E b 0.0 7v61_B 0 0 0 0 0 0 0 79 0 0 0 0 0 0 0 0 0 21 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 359 L E b 2.8 7v61_B 0 0 0 0 0 0 0 0 94 6 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="L->K,A: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="L->K,A: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 360 M b 2.9 7v61_B XX5 14 0 0 0 0 0 0 0 7 0 31 0 0 49 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 361 C b 14.0 7v61_B BR 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISULFID:ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 362 T b 8.4 7v61_B 14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 86 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 363 K e 58.0 7v61_B 0 0 0 14 0 0 0 0 23 0 0 0 0 14 17 9 15 7 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 364 V S e 35.3 7v61_B 0 0 0 0 0 0 0 0 0 14 0 0 0 0 0 0 0 86 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 365 T S e 27.9 7v61_B 0 0 14 0 0 14 0 0 0 0 0 19 0 0 0 0 52 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 366 M H b 15.0 7v61_B PE4:PEG:EDO:1PE:P6G 0 0 0 14 0 0 0 0 0 10 57 0 0 12 0 8 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 367 D H e 54.9 7v61_B 3ES:3EF:NIY:8JV NA:CA:MG EPE:GOL:PE4:SO4:1PE:EDO 0 0 40 31 0 0 14 0 0 0 0 0 14 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 368 D H b 17.3 7v61_B XX5:LPR:LSW 0 0 53 3 0 0 0 0 0 0 0 7 0 23 0 0 0 0 7 8 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 369 F H b 0.0 7v61_B 0 0 0 0 57 0 0 0 0 43 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 370 L H b 19.7 7v61_B 3EF:8JV:KS8 GLY:EPE:PE4:BO3:EDO 0 0 0 14 17 0 0 0 0 29 7 0 0 0 0 6 0 19 0 8 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 371 T H e 22.7 7v61_B ANGT_HUMAN:BNP_GLOBL:KNG1_HUMA:A4_HUMAN:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:BRADYKININ[4 aa]:BETA-AMYLOID PROTEIN 42[3 aa]:AMYLOID BETA A4 PROTEIN[2 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ILE-PRO-PRO[3 aa]:VAL-PRO-PRO[3 aa] LPR:XX5:X95:RX3:3ES:LSW:3EF:SAC:LYS:GLN:GLU:ASP:D0W:D0Z:FT8:KS8:8KC:8J9:8JV EPE:SO4:EDO 0 0 0 0 0 0 0 9 0 0 0 0 0 14 0 7 52 18 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 372 A H b 0.0 7v61_B 53 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 40 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 373 H H b 0.0 7v61_B 0 0 0 0 7 0 93 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 374 H H b 13.1 7v61_B ANGT_HUMAN:BNP_GLOBL:KNG1_HUMA:A4_HUMAN:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ[4 aa]:BETA-AMYLOID PROTEIN 42[3 aa]:AMYLOID BETA A4 PROTEIN[2 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ILE-PRO-PRO[3 aa]:VAL-PRO-PRO[3 aa] LPR:X8Z:XX5:EAL:MCO:NXA:RX3:X92:X93:X94:X95:RX4:K26:3ES:SLC:KAF:KAW:LSW:1IU:3EF:SAC:LYS:PRO:GLN:GLU:ASP:BJ2:D0W:D0Z:FT8:KSN:KS8:8KC:8J9:8JV ZN ACT:GLY:FLC:EPE:SO4 0 0 0 0 0 0 86 0 0 0 0 0 0 0 0 14 0 0 0 0 BINDING:/ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":BINDING:/ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 375 E H b 7.0 7v61_B ANGT_HUMAN:BNP_GLOBL:KNG1_HUMA:A4_HUMAN:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ[4 aa]:BETA-AMYLOID PROTEIN 42[3 aa]:AMYLOID BETA A4 PROTEIN[2 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:ILE-PRO-PRO[3 aa]:VAL-PRO-PRO[3 aa] LPR:X8Z:NXA:XX5:EAL:MCO:RX3:X92:X93:X94:X95:RX4:K26:3ES:SLC:KAF:KAW:LSW:1IU:3EF:SAC:LYS:MLT:GLN:GLU:ASP:BJ2:D0W:D0Z:FT8:KSN:KS8:8KC:8J9:8JV ZN:CL alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. ACT:FLC:SO4:GLY:BO3 0 0 0 79 0 0 0 0 0 14 0 0 0 7 0 0 0 0 0 0 ACT_SITE:/note="Proton acceptor" ECO:0000305|PubMed:14754895, ECO:0000305|PubMed:27217402":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":ACT_SITE:/note="Proton acceptor" ECO:0000305|PubMed:14754895, ECO:0000305|PubMed:27217402":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 376 M H b 0.0 7v61_B 0 0 0 0 0 0 0 0 0 28 72 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 377 G H b 0.0 7v61_B 0 0 0 0 0 86 0 0 0 0 0 0 0 0 0 0 0 14 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 378 H H b 6.3 7v61_B ANGT_HUMAN:BNP_GLOBL:KNG1_HUMA:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:BRADYKININ[4 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:ILE-PRO-PRO[3 aa]:VAL-PRO-PRO[3 aa] LPR:X8Z:XX5:EAL:MCO:RX3:X92:X93:X94:X95:RX4:K26:3ES:SLC:KAF:KAW:LSW:1IU:3EF:BJ2:D0W:D0Z:FT8:KSN:KS8:BCN:8KC:8J9:8JV ZN alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. ACT:EPE:FLC:SO4:P6G:PEG:EDO:BO3:PG4:1PE:PGE 0 0 0 0 0 0 86 0 0 0 0 0 0 14 0 0 0 0 0 0 BINDING:/ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":BINDING:/ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 379 I H b 0.0 7v61_B 0 0 0 0 0 0 0 75 0 0 0 0 0 0 0 0 14 11 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 380 Q H b 3.1 7v61_B 0 0 0 7 0 0 0 0 0 0 0 0 0 79 0 0 0 0 0 14 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 381 Y H b 0.4 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 382 D H b 7.4 7v61_B ANGT_HUMAN:BNP_GLOBL:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR.. RX3:RX4:K26:3ES:KAF:KAW:1IU:3EF:BJ2:D0W:D0Z:BCN FLC:P6G:PEG:EDO:BO3:SO4:PG4:1PE:PGE 0 0 23 0 38 0 0 0 0 0 0 0 0 14 0 0 0 0 0 25 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 383 M T b 18.8 7v61_B SPIKE_CVHNL:SPIKE_SARS2:Spike glycoprotein[110 aa]:Spike glycoprotein[1048 aa] PEG 0 0 0 0 0 0 0 0 0 44 42 0 0 0 0 0 0 0 0 14 MUTAGEN:/note="M->A: Slightly inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="M->A: Slightly inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 384 A T b 14.3 7v61_B EDO:PEG 23 0 0 0 0 0 7 0 0 14 0 0 0 56 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 385 Y G b 1.3 7v61_B ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR.. BCN P6G:PEG:1PE 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 386 A G e 45.5 7v61_B SPIKE_CVHNL:SPIKE_SARS2:Spike glycoprotein[110 aa]:Spike glycoprotein[1066 aa]:Spike protein S1[195 aa]:Spike glycoprotein[1068 aa]:Spike protein S1[131 aa]:Spike glycoprotein[981 aa]:Spike glycoprotein[1031 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[1048 aa]:Spike glycoprotein[1024 aa]:Spike glycoprotein[185 aa] EDO:PEG 23 0 0 8 0 0 0 0 51 0 0 0 0 18 0 0 0 0 0 0 MUTAGEN:/note="A->L: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein. In sACE2.v2.2; increases interaction with RBD domain of SARS-CoV-2 spike protein; when associated with Y-27 and Y-330.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="A->L: Increases slightly the interaction with RBD domain of SARS-CoV-2 spike protein. In sACE2.v2.2; increases interaction with RBD domain of SARS-CoV-2 spike protein; when associated with Y-27 and Y-330.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 387 A G e 88.4 7v61_B SPIKE_CVHNL:SPIKE_SARS2:Spike glycoprotein[110 aa]:Spike protein S1[131 aa]:Spike glycoprotein[1048 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. EPE:PEG 13 0 45 0 0 6 12 0 3 0 0 7 0 8 3 0 0 3 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 388 Q S b 16.8 7v61_B NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. EPE 0 0 0 0 0 0 0 0 0 26 0 0 0 74 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 389 P e 27.1 7v61_B SPIKE_SARS2:Spike glycoprotein[1048 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. EPE 0 0 0 0 0 0 6 0 0 0 0 0 74 0 0 21 0 0 0 0 MUTAGEN:/note="P->A: Slightly inhibits interaction with SARS-CoV spike glycoprotein.":MUTAGEN:/note="P->D: Increases very slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="P->A: Slightly inhibits interaction with SARS-CoV spike glycoprotein.":MUTAGEN:/note="P->D: Increases very slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 390 F G b 13.4 7v61_B ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 1[13 aa]:Peptide 2[15 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] PG0 beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. P6G:EDO:PEG:GOL:PGE 8 0 0 0 31 0 0 7 0 14 0 0 0 0 0 0 0 37 0 4 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 391 L G e 21.9 7v61_B ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 1[13 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] PG0 beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. P6G:PEG:EDO 7 0 0 0 0 0 0 7 0 37 0 0 0 0 0 17 13 20 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 392 L G b 3.4 7v61_B 0 0 0 0 39 0 0 0 0 35 0 0 0 0 0 0 0 0 0 26 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 393 R e 24.1 7v61_B SPIKE_CVHSA:SPIKE_CVHNL:D9IEJ2_BPT4:SPIKE_SARS2:A0A6G6A1M4_9BETC:A0A7U0MIF7_SARS2:A0A6G6A2Q2_9BETC:A0A7D6P0R3_9BETC:SPIKE_SARS:Spike glycoprotein[173 aa]:Spike glycoprotein[110 aa]:Spike glycoprotein,Fibritin[1076 aa]:Spike protein S1[194 aa]:SARS-CoV-2 chimeric RBD[193 aa]:Spike glycoprotein[251 aa]:Spike glycoprotein[643 aa]:Spike glycoprotein[1069 aa]:Spike glycoprotein[1065 aa]:Spike protein S1[195 aa]:SARS-CoV-2 Receptor binding domain[195 aa]:Spike glycoprotein[1068 aa]:Spike protein S1[196 aa]:Spike glycoprotein[194 aa]:Spike protein S1[185 aa]:Spike protein S1[187 aa]:Spike protein S1[197 aa]:Spike protein S1[131 aa]:Spike glycoprotein[981 aa]:Spike protein S1[203 aa]:Spike protein S1[201 aa]:Spike protein S1[200 aa]:BANAL 236 coronavirus spike receptor-binding domai..:Spike protein S1[184 aa]:Surface glycoprotein[194 aa]:Spike glycoprotein[1040 aa]:Spike glycoprotein[201 aa]:Spike glycoprotein[1035 aa]:Spike glycoprotein[1038 aa]:Spike glycoprotein[188 aa]:Spike glycoprotein[184 aa]:Spike glycoprotein[1079 aa]:Spike glycoprotein[1060 aa]:RshSTT182/200 coronavirus receptor binding domain ..:RshSTT182/200 coronavirus receptor binding domain[..:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Spike glycoprotein[1037 aa]:Spike glycoprotein[1034 aa]:Spike glycoprotein[676 aa]:Spike glycoprotein[192 aa]:Peptide 1[13 aa]:Peptide 2[15 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa]:PRD-0038[174 aa]:Spike protein S1[172 aa] NAG:FT8:BCN CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. EPE:P6G:EDO:1PE:PEG:GOL:PGE:PG4 0 0 0 0 0 0 0 0 0 0 0 0 0 7 93 0 0 0 0 0 MUTAGEN:/note="R->A: Slightly inhibits interaction with SARS-CoV spike glycoprotein.":MUTAGEN:/note="R->K: Increases very slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="R->A: Slightly inhibits interaction with SARS-CoV spike glycoprotein.":MUTAGEN:/note="R->K: Increases very slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 394 N S e 55.2 7v61_B ANGT_HUMAN:BNP_GLOBL:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Bradykinin potentiating peptide b[11 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Peptide 1[13 aa]:Peptide 2[15 aa]:Peptide 6[12 aa]:Cyclic peptide 2[15 aa] K26:3ES:RX4:D0Z:FT8:BCN CL beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. EPE:PEG:P6G:TRS:EDO:PGE:ACT:1PE:PG4 0 0 0 40 0 13 0 0 0 0 0 23 0 0 6 7 12 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 395 G b 2.4 7v61_B K26 CL TRS:PGE 8 0 0 0 0 78 0 0 0 0 0 0 0 14 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 396 A S b 8.9 7v61_B TRS:PGE 92 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 397 N S b 3.6 7v61_B PGE 0 0 0 0 0 0 0 0 0 0 0 79 0 0 0 21 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 398 E T b 16.6 7v61_B 3ES CL PEG:EDO:PGE 0 0 0 23 0 0 0 0 0 0 0 0 77 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 399 G T b 0.0 7v61_B 7 0 0 0 0 79 0 0 0 0 0 0 0 0 0 0 0 14 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 400 F T b 0.0 7v61_B 0 0 0 0 86 0 0 14 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 401 H H b 18.8 7v61_B ANGT_HUMAN:BNP_GLOBL:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR.. RX3:RX4:K26:3ES:KAF:KAW:1IU:3EF:BJ2:D0W:D0Z:BCN CL:ZN alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. EPE:FLC:P6G:PEG:EDO:PGE:BO3:SO4:PG4:1PE 0 0 0 7 0 0 79 0 0 0 0 0 0 0 0 0 14 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 402 E H e 38.2 7v61_B ANGT_HUMAN:BNP_GLOBL:KNG1_HUMA:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:BRADYKININ[4 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ILE-PRO-PRO[3 aa]:VAL-PRO-PRO[3 aa] LPR:X8Z:XX5:EAL:MCO:RX3:X92:X93:X94:X95:RX4:K26:3ES:SLC:KAF:KAW:LSW:1IU:3EF:BJ2:D0W:D0Z:FT8:KSN:KS8:BCN:8KC:8J9:8JV ZN:CL alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. ACT:SO4:P6G:PEG:EDO:PG4:1PE:BO3:PGE 0 0 14 86 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 BINDING:/ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":BINDING:/ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 403 A H b 0.0 7v61_B ZN 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 404 V H b 1.3 7v61_B 0 0 0 0 0 0 0 51 0 0 0 0 0 0 0 0 0 49 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 405 G H b 0.0 7v61_B ZN 21 0 0 0 0 79 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 406 E H b 18.6 7v61_B RX3:X93:X94:X95:3ES:KAF:KAW:LSW:3EF:NIY:D0W:D0Z:8KC:8J9:KS8 ZN GLY:ACT:BO3:SO4 0 0 56 23 0 0 0 0 0 0 0 14 0 0 0 7 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 407 I H b 0.0 7v61_B 14 0 0 0 0 0 0 32 0 0 0 0 0 0 0 0 0 53 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 408 M H b 1.4 7v61_B 7 0 0 0 14 0 0 14 0 39 26 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 409 S H e 21.9 7v61_B 54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 46 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 410 L H b 11.8 7v61_B 0 0 0 0 0 0 14 0 0 86 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 411 S H b 0.0 7v61_B 0 0 0 0 0 0 0 0 0 14 0 0 0 0 0 86 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 412 A H b 0.0 7v61_B 23 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14 0 63 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 413 A T b 18.8 7v61_B PE4:PEG:EDO:1PE:P6G 29 0 0 0 0 0 0 0 0 0 8 0 0 0 0 49 14 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 414 T S b 5.2 7v61_B 0 0 0 0 0 0 0 0 0 0 0 14 0 0 0 14 71 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 415 P H e 23.3 7v61_B BO3:GOL 8 0 0 0 0 0 7 0 0 0 0 0 86 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 416 K H e 56.6 7v61_B NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. 6 0 0 7 0 0 18 0 58 0 0 6 0 0 0 5 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 417 H H b 6.3 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL 0 0 0 0 0 0 69 0 0 0 0 0 0 0 0 0 0 0 0 31 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 418 L H b 0.0 7v61_B PE4:PEG:EDO:1PE:P6G 0 0 0 0 0 0 0 0 0 93 7 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 419 K T e 37.7 7v61_B 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. ACE2_PAGLA:ACE2_HUMAN:Angiotensin-converting enzyme 2[597 aa] PEG 0 0 0 12 0 0 18 0 31 7 0 0 0 12 4 0 0 0 0 17 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 420 S T e 72.7 7v61_B NAG:NDG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-alp..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. PEG:EDO:GOL 18 0 0 0 0 0 0 0 17 0 0 0 0 0 6 53 6 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 421 I T b 13.5 7v61_B PE3:XPE:PE8:NAG:12P 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. P6G:PEG:PGE:GOL:1PE 0 0 0 0 0 0 0 51 0 16 0 0 0 14 7 0 0 12 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 422 G T e 53.6 7v61_B NAG PEG:TRS 0 0 0 0 0 60 0 0 14 0 0 19 0 0 0 7 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 423 L b 1.7 7v61_B NAG TRS 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 424 L S b 16.3 7v61_B PE4:ACT:BO3:TRS 0 0 0 0 0 0 0 8 0 78 0 0 0 0 0 0 0 14 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 425 S e 64.1 7v61_B NAG TRS 4 0 6 8 0 0 0 0 16 1 0 0 7 0 0 55 0 0 0 0 MUTAGEN:/note="SPD->PSN: Slightly inhibits interaction with SARS- CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="SPD->PSN: Slightly inhibits interaction with SARS- CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 426 P S e 74.4 7v61_B 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-alp.. ACE2_PAGLA:ACE2_HUMAN:Angiotensin-converting enzyme 2[597 aa] 2 0 1 16 1 2 1 1 1 2 1 1 24 8 1 30 5 2 0 1 MUTAGEN:/note="SPD->PSN: Slightly inhibits interaction with SARS- CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="SPD->PSN: Slightly inhibits interaction with SARS- CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 427 D S e 98.1 7v61_B 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-alp.. ACT:BO3 8 0 19 19 0 3 14 0 0 0 0 24 7 6 0 0 0 0 0 0 MUTAGEN:/note="SPD->PSN: Slightly inhibits interaction with SARS- CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="SPD->PSN: Slightly inhibits interaction with SARS- CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 428 F e 39.7 7v61_B 1 0 1 1 30 12 7 1 1 16 0 1 1 1 1 1 1 12 0 12 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 429 Q e 80.1 7v61_B 0 0 18 0 0 16 4 0 0 0 0 0 0 20 8 7 13 12 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 430 E e 20.6 7v61_B NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. ACE2_PAGLA:ACE2_HUMAN:Angiotensin-converting enzyme 2[597 aa] GOL 1 0 10 29 0 7 0 15 0 8 0 6 0 0 6 16 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 431 D e 33.3 7v61_B NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. ACE2_PAGLA:ACE2_HUMAN:Angiotensin-converting enzyme 2[597 aa] BO3:EDO 0 0 70 0 0 16 0 0 14 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 432 N T e 71.5 7v61_B NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. PEG:EDO 0 0 20 13 0 0 0 0 0 0 0 22 7 0 0 13 6 0 0 16 CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 433 E T e 31.7 7v61_B NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. PEG 0 0 0 71 0 0 0 0 8 0 0 7 0 0 0 14 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 434 T H b 14.9 7v61_B ACT:BO3:GOL 12 0 0 10 0 7 13 0 0 0 0 0 0 0 0 19 23 14 0 3 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 435 E H e 20.6 7v61_B beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. PEG:GOL 0 0 32 29 0 0 0 14 0 0 0 5 0 0 20 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 436 I H b 9.4 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. BO3:EDO 0 0 0 0 0 0 0 87 0 7 0 0 0 0 0 0 0 7 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 437 N H b 1.8 7v61_B ACT:BO3 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 438 F H e 24.4 7v61_B ACT:EDO:BO3:GOL 0 0 0 0 55 0 0 0 14 0 0 0 0 20 0 0 0 0 0 11 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 439 L H b 0.0 7v61_B 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 440 L H b 0.6 7v61_B 0 0 0 0 20 0 0 0 0 40 26 0 0 0 0 0 0 0 0 14 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 441 K H e 40.6 7v61_B PE4:ACT:PEG:EDO:1PE:BO3:P6G 0 0 0 0 0 7 0 0 75 12 0 7 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 442 Q H e 23.5 7v61_B PE4:1PE:P6G:PEG 0 0 0 14 0 0 0 7 0 0 30 0 0 37 0 0 12 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 443 A H b 0.0 7v61_B 86 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 444 L T b 0.6 7v61_B 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 445 T T e 27.3 7v61_B 3EF:LYS:8KC MG GLY:PE4:1PE:BO3:EDO 0 0 31 32 0 0 0 0 0 0 0 0 0 0 0 8 29 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 446 I T b 9.9 7v61_B 3EF:3ES GLY:BO3 0 0 0 0 0 0 0 23 63 0 0 0 0 0 0 14 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 447 V G b 0.0 7v61_B 0 0 0 0 14 0 0 53 0 0 0 0 0 0 0 0 0 33 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 448 G G b 3.6 7v61_B 43 0 0 0 0 23 0 0 0 0 0 0 0 0 0 0 14 20 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 449 T G b 3.2 7v61_B ANGT_HUMAN:BNP_GLOBL:KNG1_HUMA:A4_HUMAN:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:BRADYKININ[4 aa]:BETA-AMYLOID PROTEIN 42[3 aa]:AMYLOID BETA A4 PROTEIN[2 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ILE-PRO-PRO[3 aa]:VAL-PRO-PRO[3 aa] X8Z:LPR:NXA:EAL:MCO:RX3:X93:X95:RX4:3ES:SLC:KAF:KAW:LSW:1IU:9X6:3EF:ASP:PRO:MLT:LYS:VAL:SER:NIY:D0W:D0Z:FT8:KSN:BCN:8KC:8J9:8JV FLC 0 0 0 0 63 0 0 0 14 0 0 0 0 0 0 0 23 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 450 L H b 0.0 7v61_B 0 0 0 0 0 0 0 22 0 74 0 0 0 0 0 0 0 4 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 451 P H b 0.0 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 452 F H b 2.4 7v61_B 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 453 T H b 0.0 7v61_B 12 0 0 0 0 25 0 0 0 0 0 0 0 0 0 26 37 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 454 Y H b 7.4 7v61_B EDO 0 0 0 0 12 0 0 14 0 0 0 0 0 0 0 0 0 0 0 74 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 455 M H b 0.0 7v61_B CL 22 0 0 0 0 0 0 0 0 43 23 0 0 0 0 0 12 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 456 L H b 0.0 7v61_B 14 0 0 0 0 0 0 21 0 23 12 0 0 0 0 0 0 30 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 457 E H b 0.5 7v61_B MLA 0 0 77 23 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 458 K H e 26.4 7v61_B BR PG4:EDO:PGE:PEG:1PE:BO3 0 0 0 3 0 0 0 0 49 0 0 14 0 34 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 459 W H b 0.4 7v61_B 0 0 0 0 7 0 0 0 0 0 0 0 0 0 0 0 0 0 74 20 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 460 R H b 0.0 7v61_B MLA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 461 W H b 3.6 7v61_B MLA ACT:BO3:EDO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 78 22 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 462 M H b 19.8 7v61_B BR EDO:PGE:PG4:1PE:BO3 14 0 7 14 0 6 0 0 7 0 23 5 0 0 19 6 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 463 V H b 5.3 7v61_B 0 0 0 0 0 0 0 7 0 26 0 0 0 0 0 0 0 68 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 464 F H b 1.4 7v61_B 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 465 K T e 34.4 7v61_B ACT:BO3 0 0 40 0 0 0 0 0 16 0 0 0 0 3 23 17 0 0 0 0 MUTAGEN:/note="KGE->QDK: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="KGE->QDK: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 466 G T e 66.7 7v61_B 0 0 3 0 0 85 0 0 0 0 0 8 0 0 4 0 0 0 0 0 MUTAGEN:/note="KGE->QDK: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="KGE->QDK: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 467 E S e 59.8 7v61_B ACT:PG4:PEG:EDO:BO3:PGE:1PE 3 0 7 30 0 0 0 0 3 0 0 0 0 6 11 19 21 0 0 0 MUTAGEN:/note="KGE->QDK: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="KGE->QDK: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 468 I S b 2.9 7v61_B PG4:EDO:PGE:1PE 6 0 0 0 0 0 0 49 0 8 0 0 0 0 0 0 17 20 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" I->V:LB/B:-: -; 469 P e 49.6 7v61_B EDO 0 0 20 0 0 0 0 0 0 0 0 0 54 0 0 7 19 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 470 K T e 55.7 7v61_B ACT 0 0 0 8 0 0 0 0 71 0 0 0 11 0 10 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 471 D T e 68.5 7v61_B ACT 6 0 6 32 0 0 0 7 0 0 0 14 7 4 0 25 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 472 Q S e 31.1 7v61_B ACT 0 0 0 6 0 0 0 0 21 0 0 25 0 31 11 0 7 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 473 W H b 3.6 7v61_B ACT 0 0 0 0 0 0 0 0 0 14 0 0 0 0 0 0 0 0 42 43 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 474 M H b 1.9 7v61_B ACT:EDO 0 0 0 0 0 0 0 0 0 0 19 77 0 0 0 0 3 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 475 K H e 52.4 7v61_B disordered segment of collectrin homology domain[1.. ACT:EDO:GOL 0 20 14 4 0 0 0 0 13 0 0 0 0 32 0 7 0 0 0 11 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 476 K H e 29.7 7v61_B ACT:PG4:PEG:PGE:EDO:1PE 12 0 11 26 0 8 0 0 29 0 0 0 0 0 14 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 477 W H b 5.2 7v61_B CL:BR EDO 0 0 0 0 20 0 0 0 0 0 0 0 0 0 0 0 0 0 80 0 BINDING:/ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":BINDING:/ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 478 W H b 4.4 7v61_B CL:BR:ZN EDO:PGE:GOL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 479 E H e 42.2 7v61_B BCN PG4:PEG:PGE:EDO:1PE 0 0 0 37 0 0 7 0 12 0 0 7 0 8 0 19 0 0 0 11 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 480 M H b 6.8 7v61_B CL PG4:PGE:PEG:1PE:BO3 0 0 0 0 7 0 0 14 0 42 31 7 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 481 K H b 4.7 7v61_B CL:BR EDO 0 0 0 0 0 0 0 0 23 0 0 0 0 0 77 0 0 0 0 0 BINDING:/ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774":MUTAGEN:/note="K->Q: About 80% loss of angiotensin I cleavage.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":BINDING:/ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774":MUTAGEN:/note="K->Q: About 80% loss of angiotensin I cleavage.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 482 R H b 13.8 7v61_B PGE 0 7 6 6 0 0 0 0 0 26 0 14 0 0 23 8 11 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 483 E H e 68.3 7v61_B GOL:BO3 0 0 0 39 0 0 0 0 58 0 0 3 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 484 I T b 10.5 7v61_B EDO:BO3 0 0 0 0 8 0 0 23 0 0 0 0 0 0 0 0 0 0 0 69 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 485 V T b 4.7 7v61_B 0 0 0 14 0 8 0 0 0 0 0 0 0 43 0 12 0 23 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 486 G b 0.0 7v61_B 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 487 V E b 2.0 7v61_B 0 0 0 0 0 0 0 23 0 26 0 0 0 0 0 0 0 51 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 488 V E b 0.0 7v61_B 0 37 0 20 0 0 0 0 0 0 0 0 0 0 14 0 0 23 0 7 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 489 E b 7.5 7v61_B EDO:GOL 5 0 0 23 0 0 0 0 0 0 0 0 58 0 0 14 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 490 P S b 7.8 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 491 V S b 2.7 7v61_B beta-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. ACT:EDO:IMD:BO3 3 0 0 0 0 0 0 0 0 10 0 0 0 14 0 0 0 72 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 492 P b 10.9 7v61_B disordered segment of collectrin homology domain[1.. FUC alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. ACT:EDO:IMD:BO3:GOL 4 0 0 0 8 0 0 7 0 0 0 0 59 0 0 5 0 17 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 493 H b 8.9 7v61_B ACT:IMD:EDO:GOL 0 0 0 0 0 0 23 0 0 0 0 0 0 0 63 0 0 0 0 14 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 494 D e 54.3 7v61_B NAG:FUC 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:beta-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. ACT:IMD 0 0 23 0 0 0 0 0 0 0 0 25 0 0 0 35 17 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 495 E T e 26.6 7v61_B 0 0 7 60 0 0 0 0 0 0 0 0 0 19 0 0 14 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 496 T T e 44.2 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:beta-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. ACT 0 0 10 0 0 16 0 0 20 0 0 0 0 7 0 19 28 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 497 Y b 8.3 7v61_B NAG:FUC 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:beta-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. ACT:IMD 0 0 52 0 0 0 6 0 0 0 0 19 0 0 0 0 0 0 0 23 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 498 C b 0.7 7v61_B 0 23 0 0 63 0 0 0 0 14 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 499 D G b 3.1 7v61_B CL:BR:ZN EDO 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 500 P G b 2.3 7v61_B CL:ZN 25 0 1 1 1 1 0 1 1 1 0 1 63 1 1 1 1 1 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 501 A G b 0.0 7v61_B 24 0 1 1 1 45 0 1 1 1 0 1 20 1 1 1 1 1 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 502 S G b 0.0 7v61_B EDO 61 4 0 0 0 0 0 0 0 0 0 0 0 0 0 35 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 503 L S b 3.4 7v61_B ANGT_HUMAN:BNP_GLOBL:KNG1_HUMA:A4_HUMAN:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:BRADYKININ[4 aa]:BETA-AMYLOID PROTEIN 42[3 aa]:AMYLOID BETA A4 PROTEIN[2 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ILE-PRO-PRO[3 aa]:VAL-PRO-PRO[3 aa] LPR:X8Z:NXA:EAL:MCO:RX3:X92:X93:X94:X95:RX4:3ES:SLC:KAF:KAW:LSW:1IU:9X6:3EF:ASP:PRO:MLT:LYS:VAL:SER:NIY:BJ2:D0W:D0Z:FT8:KSN:KS8:BCN:8KC:8J9:8JV ACT:FLC:EPE:EDO 0 0 0 0 0 0 0 0 63 37 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 504 F H e 34.0 7v61_B ANGT_HUMAN:BNP_GLOBL:KNG1_HUMA:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:BRADYKININ[4 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:VAL-PRO-PRO[3 aa]:Cyclic peptide 2[15 aa] LPR:XX5:EAL:RX3:X92:X93:X94:X95:RX4:K26:3ES:KAF:KAW:LSW:1IU:3EF:BJ2:FT8:KSN:KS8:8KC:8J9:8JV alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. ACT:PEG 0 0 0 0 61 0 0 14 0 0 0 0 0 0 0 0 0 0 0 25 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 505 H H b 8.9 7v61_B ANGT_HUMAN:BNP_GLOBL:KNG1_HUMA:A4_HUMAN:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:BRADYKININ[4 aa]:BETA-AMYLOID PROTEIN 42[3 aa]:AMYLOID BETA A4 PROTEIN[2 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ILE-PRO-PRO[3 aa]:VAL-PRO-PRO[3 aa] LPR:X8Z:NXA:XX5:EAL:MCO:RX3:X92:X93:X94:X95:RX4:K26:3ES:SLC:KAF:KAW:LSW:1IU:9X6:3EF:SAC:ASP:LYS:PRO:MLT:GLN:VAL:GLU:SER:NIY:BJ2:D0W:D0Z:FT8:KSN:KS8:BCN:8KC:8J9:8JV ZN ACT:FLC:EPE:GLY:PEG:SO4:EDO 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 ACT_SITE:/note="Proton donor" ECO:0000305|PubMed:14754895":MUTAGEN:/note="H->A: Complete loss of enzyme activity.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":ACT_SITE:/note="Proton donor" ECO:0000305|PubMed:14754895":MUTAGEN:/note="H->A: Complete loss of enzyme activity.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 506 V H b 0.0 7v61_B 1 0 1 1 1 1 0 36 1 1 0 1 1 1 1 1 1 51 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 507 S H b 0.0 7v61_B 11 0 9 1 1 1 0 1 1 1 0 1 44 1 1 26 1 1 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 508 N T e 22.4 7v61_B BNP_GLOBL:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Bradykinin potentiating peptide b[11 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Cyclic peptide 2[15 aa] 3ES:FT8 EPE:P6G:EDO:PGE 35 0 0 4 0 5 0 0 0 0 0 46 0 0 0 10 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 509 D T b 19.1 7v61_B BNP_GLOBL:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:Bradykinin potentiating peptide b[11 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:Cyclic peptide 2[15 aa] 3ES EPE:EDO 0 0 42 0 0 0 0 0 0 0 0 28 0 0 0 24 0 6 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 510 Y e 47.4 7v61_B ANGT_HUMAN:BNP_GLOBL:KNG1_HUMA:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:BRADYKININ[4 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR..:ILE-PRO-PRO[3 aa]:Peptide 2[15 aa]:Cyclic peptide 2[15 aa] LPR:XX5:EAL:RX3:X92:X93:X95:RX4:K26:3ES:KAF:KAW:LSW:1IU:3EF:BJ2:FT8:8KC:8J9:8JV:KS8:LFI beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. EPE:EDO:PGE 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17 60 0 23 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 511 S b 6.2 7v61_B 3ES:MLA:FT8 CL PGE:EDO 0 0 0 20 0 0 0 0 0 0 0 0 43 0 0 37 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 512 F b 0.0 7v61_B ANGT_HUMAN:BNP_GLOBL:KNG1_HUMA:A4_HUMAN:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:BRADYKININ[4 aa]:BETA-AMYLOID PROTEIN 42[3 aa]:AMYLOID BETA A4 PROTEIN[2 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ILE-PRO-PRO[3 aa]:VAL-PRO-PRO[3 aa] LPR:X8Z:NXA:EAL:MCO:RX3:X92:X93:X94:X95:RX4:3ES:SLC:KAF:KAW:LSW:1IU:9X6:MLA:3EF:ASP:PRO:MLT:LYS:VAL:SER:NIY:BJ2:D0W:D0Z:FT8:KSN:KS8:BCN:8KC:8J9:8JV ACT:FLC:EPE 0 0 0 0 23 0 0 0 0 0 0 0 0 14 0 0 0 0 0 63 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 513 I T b 1.2 7v61_B MLA CL 0 0 0 0 0 0 0 63 0 20 0 0 0 0 0 0 0 17 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 514 R H e 37.5 7v61_B Bradykinin potentiating peptide b[11 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR.. XX5:3ES:K26:3EF:D0Z:FT8:BCN CL EPE:PEG:SO4:EDO:PGE 0 0 0 0 0 0 14 0 0 0 0 0 0 0 86 0 0 0 0 0 MUTAGEN:/note="R->Q: About 50% loss of angiotensin I cleavage but two-fold greater activity with angiotensin II.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="R->Q: About 50% loss of angiotensin I cleavage but two-fold greater activity with angiotensin II.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 515 Y H e 25.2 7v61_B ANGT_HUMAN:BNP_GLOBL:KNG1_HUMA:A4_HUMAN:ANGIOTENSIN-2[5 aa]:BRADYKININ-POTENTIATING PEPTIDE B[6 aa]:ANGIOTENSIN-2[8 aa]:BRADYKININ-POTENTIATING PEPTIDE B[11 aa]:BRADYKININ[4 aa]:BETA-AMYLOID PROTEIN 42[3 aa]:AMYLOID BETA A4 PROTEIN[2 aa]:Bradykinin potentiating peptide b[11 aa]:Bradykinin potentiating peptide b[5 aa]:ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR..:ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR..:ILE-PRO-PRO[3 aa]:VAL-PRO-PRO[3 aa] LPR:X8Z:NXA:XX5:EAL:MCO:RX3:X92:X93:X94:X95:RX4:K26:3ES:SLC:KAF:KAW:LSW:1IU:9X6:3EF:SAC:ASP:LYS:PRO:MLT:GLN:VAL:GLU:SER:NIY:BJ2:D0W:D0Z:FT8:KSN:KS8:BCN:8KC:8J9:8JV ZN:CL ACT:FLC:EPE:SO4:GLY:EDO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14 0 0 0 86 BINDING:/ligand="substrate":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":BINDING:/ligand="substrate":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 516 Y H b 0.0 7v61_B 14 0 0 0 51 0 0 0 0 12 0 0 0 0 0 0 0 0 0 23 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 517 T H b 0.0 7v61_B 8 0 0 0 0 0 0 3 0 7 0 0 0 0 0 0 37 45 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 518 R H b 11.1 7v61_B CL:ZN ACT 14 0 0 0 0 7 0 0 0 0 0 0 0 0 37 42 0 0 0 0 MUTAGEN:/note="R->G: Increases very slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="R->G: Increases very slightly the interaction with RBD domain of SARS-CoV-2 spike protein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 519 T H b 0.0 7v61_B X93:X95:RX3:3ES:LSW:3EF:LYS:VAL:D0W:D0Z:KS8:8KC:8J9 CL GLY:ACT:BO3 0 0 0 0 42 0 14 0 0 7 0 0 0 0 0 0 37 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 520 L H b 1.1 7v61_B 0 0 0 0 0 0 0 74 0 20 0 0 0 0 0 0 0 6 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 521 Y H b 0.4 7v61_B 0 0 0 0 8 0 0 38 0 32 0 0 0 0 0 0 0 0 0 23 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 522 Q H b 2.6 7v61_B ZN 0 0 0 0 0 0 0 0 14 0 0 0 0 86 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 523 F H b 0.0 7v61_B 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 524 Q H b 3.6 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 525 F H b 0.0 7v61_B 0 0 0 0 79 0 0 14 0 7 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 526 Q H b 2.0 7v61_B 0 0 0 0 0 0 55 0 0 14 0 0 0 19 0 0 0 0 0 12 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 527 E H e 22.6 7v61_B PEG:ACT:EDO:BO3 0 0 0 61 0 0 0 0 39 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 528 A H b 9.8 7v61_B 88 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 529 L H b 0.0 7v61_B 12 0 0 0 0 0 0 0 0 88 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 530 C H b 3.3 7v61_B 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISULFID:ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 531 Q H e 66.3 7v61_B NA EDO 0 0 0 7 0 0 0 12 19 0 0 0 14 28 20 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 532 A H b 16.1 7v61_B NA SO4 52 0 1 7 1 1 0 7 15 1 0 1 1 1 1 1 10 1 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 533 A T e 20.5 7v61_B SO4:EDO 80 0 1 1 1 1 0 1 1 1 0 1 1 1 1 8 1 1 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 534 K T e 74.1 7v61_B ACE2_PAGLA:ACE2_HUMAN:Angiotensin-converting enzyme 2[597 aa] 1 0 1 1 1 46 0 1 24 1 0 12 1 6 1 1 1 1 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 535 H e 30.4 7v61_B NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. EDO 1 0 1 1 1 1 57 1 1 1 0 7 1 14 1 1 7 1 0 4 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 536 E e 85.4 7v61_B NAG:BMA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. ACE2_PAGLA:ACE2_HUMAN:Angiotensin-converting enzyme 2[597 aa] 0 0 3 42 0 0 0 0 4 0 0 3 0 6 0 7 21 7 0 8 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 537 G S e 60.7 7v61_B NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. 8 0 0 0 0 74 0 0 0 6 0 0 0 0 7 0 0 0 0 6 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 538 P e 41.9 7v61_B NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. EDO:PEG 4 0 0 0 0 0 0 0 0 0 0 0 79 0 0 3 14 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 539 L G b 13.5 7v61_B BR 0 0 0 0 0 0 0 14 0 86 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 540 H G b 6.3 7v61_B EDO:PEG:GOL 0 0 20 0 4 0 60 0 0 14 0 0 0 0 0 0 0 0 0 3 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 541 K G e 24.1 7v61_B NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. PEG 0 0 0 0 0 0 0 0 39 0 0 20 0 12 7 14 9 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 542 C b 2.0 7v61_B 0 86 0 14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISULFID:ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:14754895":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 543 D b 6.8 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-alp..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. EDO 0 0 79 0 0 14 0 0 0 0 0 7 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 544 I b 2.3 7v61_B EDO 0 14 0 0 0 0 0 79 0 0 0 7 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 545 S T e 23.4 7v61_B NDG:NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. EDO:GOL 7 0 0 0 8 0 0 14 0 0 0 0 0 0 0 23 0 0 0 49 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 546 N T e 91.5 7v61_B NAG:NDG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-alp..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. PE4:EDO:GOL 0 0 0 0 0 20 0 0 0 14 5 36 0 25 0 0 0 0 0 0 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19901337":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19901337":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 547 S b 4.7 7v61_B SO4:EDO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 548 T H e 51.3 7v61_B NAG PE4:SO4:EDO 6 0 0 14 0 0 0 0 52 0 0 0 0 0 0 3 25 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 549 E H e 53.8 7v61_B SO4:EDO 14 0 14 60 0 0 0 0 0 0 0 0 0 6 0 0 0 7 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 550 A H b 0.9 7v61_B 86 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 551 G H b 3.6 7v61_B GOL 0 0 0 0 0 86 0 0 0 0 0 0 0 0 0 0 14 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 552 Q H e 48.0 7v61_B 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. EDO:GOL 17 0 0 14 0 0 0 0 38 0 0 0 0 20 11 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 553 K H e 34.9 7v61_B SO4 6 0 0 0 0 0 0 7 51 15 0 0 0 0 14 8 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 554 L H b 1.1 7v61_B 0 0 0 0 12 0 0 0 0 88 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 555 F H e 32.1 7v61_B 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. EDO:GOL 26 0 0 6 3 7 6 0 0 20 0 0 0 0 25 8 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 556 N H e 35.8 7v61_B EDO:ACT 6 0 23 29 0 0 0 0 3 0 0 21 0 15 0 0 3 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 557 M H b 1.0 7v61_B 16 0 0 0 8 0 0 0 0 19 34 0 0 0 0 0 17 5 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 558 L H b 0.6 7v61_B 0 0 0 0 0 0 0 0 0 60 40 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 559 R T e 42.3 7v61_B 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. EDO:PEG:ACT 0 0 0 0 0 0 0 0 52 0 0 0 0 6 10 29 3 0 0 0 MUTAGEN:/note="R->S: Slightly inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="R->S: Slightly inhibits interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 560 L T b 5.1 7v61_B ACT 11 0 0 0 0 0 0 0 8 66 9 0 0 0 0 7 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 561 G T b 1.2 7v61_B 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 562 K T e 31.1 7v61_B ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR.. TRS:EDO:PGE 12 0 0 0 3 0 0 0 13 4 0 14 0 0 3 38 0 0 0 13 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 563 S S b 9.4 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 564 E S e 36.2 7v61_B 0 0 0 16 0 3 0 21 36 0 0 0 0 0 23 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 565 P b 11.6 7v61_B 0 0 0 0 0 0 8 0 0 0 0 0 70 3 0 5 14 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 566 W H b 1.6 7v61_B PEG 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 567 T H b 1.9 7v61_B EDO 0 0 0 0 0 0 0 0 8 14 0 0 38 11 7 0 23 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 568 L H b 17.4 7v61_B 0 0 12 45 0 0 0 0 24 20 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 569 A H b 1.8 7v61_B 68 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 0 27 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 570 L H b 0.0 7v61_B 0 0 0 0 0 0 0 0 0 81 19 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 571 E H e 35.7 7v61_B SPIKE_SARS2:Spike glycoprotein[1026 aa]:Spike glycoprotein[1047 aa] 0 0 0 63 5 0 0 0 18 0 0 0 0 13 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 572 N T e 31.5 7v61_B SO4 12 0 6 14 0 0 3 3 0 13 14 28 0 0 3 0 0 3 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 573 V T b 0.7 7v61_B 0 0 0 0 20 0 0 37 0 12 6 0 0 0 0 0 0 26 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 574 V T e 25.3 7v61_B SPIKE_SARS2:Spike glycoprotein[1047 aa] 0 0 0 0 0 0 0 0 0 0 0 12 0 0 0 14 46 28 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 575 G S e 66.7 7v61_B SPIKE_SARS2:Spike glycoprotein[1047 aa] SO4 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 576 A e 26.8 7v61_B PEG:EDO 13 0 0 29 0 0 0 4 14 0 0 0 0 19 0 16 5 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 577 K S e 44.8 7v61_B EDO 0 0 11 7 0 14 0 0 16 0 0 0 19 0 18 7 8 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 578 N S e 49.1 7v61_B NAG NA EDO:PEG 0 0 0 22 0 0 0 6 15 0 0 48 0 0 0 0 9 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 579 M b 2.9 7v61_B PEG:EDO 0 0 0 0 0 0 0 7 0 20 70 0 0 0 0 0 0 4 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 580 N e 41.8 7v61_B CL PEG:EDO:ACT 0 0 43 0 0 0 0 0 0 0 0 13 0 0 0 38 6 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 581 V S b 0.0 7v61_B 51 0 0 0 0 12 0 0 0 0 0 0 8 0 0 0 7 23 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 582 R H e 43.1 7v61_B CL PEG:ACT:EDO:BO3 8 0 0 0 0 5 0 0 35 0 0 0 0 14 12 19 6 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 583 P H b 4.7 7v61_B PEG:ACT:EDO:BO3 51 0 0 0 0 0 0 0 0 0 0 0 43 0 0 7 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 584 L H b 0.6 7v61_B 0 0 0 0 7 0 0 15 0 62 16 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 585 L H b 9.6 7v61_B EDO 12 0 0 0 0 0 0 0 0 66 23 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 586 N H e 35.8 7v61_B PEG:ACT:BO3:EDO 7 0 3 39 0 0 0 0 3 0 0 29 0 0 0 9 10 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 587 Y H b 2.6 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 588 F T b 0.5 7v61_B 0 0 0 0 79 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 589 E H e 34.7 7v61_B 0 0 0 50 0 0 0 0 33 0 0 0 0 12 0 5 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 590 P H e 31.0 7v61_B EDO:PEG 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 591 L H b 0.6 7v61_B 0 0 0 0 0 0 0 0 0 89 0 0 0 0 0 0 0 11 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 592 F H b 18.2 7v61_B EDO 0 0 0 0 23 0 0 21 0 7 10 0 0 0 12 0 20 0 0 8 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 593 T H e 40.9 7v61_B 0 0 27 9 0 0 0 0 0 0 0 14 0 14 0 0 22 15 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 594 W H b 15.5 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. PEG:BO3:EDO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 595 L H b 0.0 7v61_B EDO 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 596 K H e 43.9 7v61_B EDO 0 0 0 19 0 0 0 0 33 4 0 0 0 6 18 0 0 21 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 597 D H e 60.5 7v61_B EDO:PEG 9 0 7 31 0 0 0 0 0 0 0 15 0 9 0 0 29 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 598 Q H e 50.0 7v61_B PEG:IMD:EDO:ACT 0 0 0 47 0 0 0 0 0 0 0 0 0 38 0 0 15 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 599 N T b 8.5 7v61_B EDO 1 0 1 1 0 1 0 0 1 1 0 91 0 0 0 1 1 1 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 600 K S e 75.0 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[593 aa] GOL:EDO 1 0 1 19 0 1 8 0 8 1 0 15 0 14 29 1 1 1 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 601 N S e 100.0 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[593 aa] 0 0 0 0 0 29 0 0 0 0 0 49 0 22 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 602 S S e 36.7 7v61_B XPE P6G:PEG:PG4:PGE:EDO 0 0 7 28 0 0 0 0 0 0 0 6 0 0 0 35 0 24 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 603 F e 49.8 7v61_B 0 0 0 0 22 0 9 0 11 0 0 0 0 0 9 0 21 28 0 0 MUTAGEN:/note="F->T: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="F->T: No effect on interaction with SARS-CoV spike glycoprotein.":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 604 V e 27.3 7v61_B GOL:EDO 0 0 0 0 0 0 0 9 0 51 0 0 0 0 0 0 0 41 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 605 G S b 9.5 7v61_B MG GOL:EDO 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 606 W b 15.1 7v61_B CL:MG GOL:EDO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9 91 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 607 S e 31.2 7v61_B EDO 0 0 19 0 0 0 0 0 0 0 0 7 51 0 0 15 9 0 0 0 DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Peptidase M2":TOPO_DOM:/note="Extracellular" 608 T T e 39.6 7v61_B GOL 1 0 0 23 0 16 0 0 0 10 0 0 0 12 0 1 34 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 609 D T e 85.2 7v61_B PGE:EDO 0 0 33 25 0 11 0 0 0 0 0 16 0 7 0 0 8 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 610 W e 23.9 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[593 aa] EDO:GOL 0 0 0 0 8 16 0 0 0 0 0 0 0 0 0 0 0 0 76 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 611 S b 4.7 7v61_B PGE:EDO 4 0 0 0 0 11 0 0 0 0 0 0 0 0 21 23 41 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 612 P T b 17.1 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[593 aa] EDO 0 50 0 0 0 0 0 0 0 0 0 0 50 0 0 0 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 613 Y T b 4.8 7v61_B disordered segment of collectrin homology domain[6..:disordered segment of collectrin homology domain[1.. EDO:GOL 0 0 11 0 9 5 0 0 0 0 0 14 16 0 0 19 0 0 0 25 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 614 A S e 43.8 7v61_B disordered segment of collectrin homology domain[6.. 36 0 0 0 19 0 0 0 0 16 0 0 0 0 0 15 15 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 615 D T e 67.9 7v61_B disordered segment of collectrin homology domain[6.. 14 0 17 36 0 0 0 0 0 0 0 0 16 0 0 0 0 16 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 616 Q T e 30.1 7v61_B 0 0 16 29 0 0 0 0 0 0 0 17 0 17 14 0 7 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 617 S b 7.8 7v61_B 17 0 0 16 0 0 0 0 19 0 0 16 0 0 0 32 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 618 I E b 1.2 7v61_B 0 0 0 0 28 0 0 52 0 0 0 0 0 0 0 0 0 0 0 20 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 619 K E e 33.5 7v61_B S6A19_HUMAN:Sodium-dependent neutral amino acid transporter B(.. 0 0 0 0 0 0 18 0 42 0 0 0 19 0 0 0 21 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 620 V E b 0.0 7v61_B 18 0 0 19 0 0 0 0 0 0 0 0 0 0 0 21 0 42 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 621 R E e 24.5 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa]:SIT1[579 aa] 18 0 0 0 0 19 0 0 21 0 0 0 0 0 42 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 622 I E b 1.8 7v61_B S6A19_HUMAN:Sodium-dependent neutral amino acid transporter B(.. 0 0 0 0 0 0 0 42 0 19 0 0 0 0 0 0 18 21 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 623 S b 16.4 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa]:SIT1[579 aa] 0 0 37 0 0 0 0 0 0 0 0 0 0 0 0 63 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 624 L H b 9.6 7v61_B S6A19_HUMAN:Sodium-dependent neutral amino acid transporter B(.. 0 0 0 0 21 0 0 19 0 42 0 0 0 0 0 0 18 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 625 K H e 82.1 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa] 22 0 0 25 0 0 0 0 35 0 0 0 0 0 19 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 626 S H e 71.9 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:SIT1[573 aa] 12 0 22 0 0 0 0 0 0 0 0 0 0 0 0 29 37 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 627 A H e 31.2 7v61_B 78 0 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 628 L T e 27.0 7v61_B 0 0 0 0 0 0 0 0 25 75 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 629 G S e 36.9 7v61_B 25 0 0 0 0 75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 630 D S e 87.7 7v61_B 7 0 69 12 0 0 0 0 6 0 0 6 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 631 K S e 86.3 7v61_B 0 0 0 5 0 0 0 0 49 0 0 19 0 0 26 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 632 A e 33.0 7v61_B 74 0 0 0 26 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 633 Y e 24.8 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 26 0 74 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 634 E e 79.9 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[750 aa] 15 0 0 68 0 0 0 0 0 0 0 0 0 0 0 0 0 17 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 635 W b 15.9 7v61_B 0 0 0 26 0 0 0 0 0 0 0 0 0 0 0 0 0 0 74 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 636 N e 41.8 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 0 0 32 0 0 0 0 0 0 0 0 29 0 0 0 0 13 0 0 26 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 637 D H e 80.2 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa] 8 0 61 0 0 0 0 0 0 0 0 7 0 0 0 0 24 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 638 N H e 70.9 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 0 0 17 0 0 0 0 0 0 0 0 57 0 0 26 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" N->S:LB/B:rs1831357: -; 639 E H e 22.1 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 0 0 0 66 0 0 0 0 0 0 0 0 0 8 0 0 26 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 640 M H b 6.3 7v61_B 26 0 0 32 0 0 0 6 0 0 36 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 641 Y H e 52.6 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 0 0 0 0 7 0 0 0 0 0 0 0 0 26 0 0 0 0 0 67 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 642 L H e 41.0 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[748 aa] 0 0 0 0 0 0 0 0 0 74 0 0 0 0 0 0 0 26 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 643 F H b 0.0 7v61_B 0 0 0 0 74 0 0 0 0 26 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 644 R H e 23.7 7v61_B 0 0 0 0 0 0 0 0 15 26 0 0 0 6 52 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 645 S H e 28.1 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 32 0 0 0 0 0 0 0 0 0 0 26 0 0 0 42 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 646 S H b 12.5 7v61_B 0 0 0 26 0 0 0 0 0 0 32 0 0 0 0 42 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 647 V H b 0.0 7v61_B 0 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 0 68 0 26 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 648 A H b 4.5 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 649 Y H e 30.9 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 0 0 0 26 32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 42 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 650 A H b 0.9 7v61_B 68 0 0 0 0 0 0 0 0 0 0 0 0 0 0 32 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 651 M H b 0.0 7v61_B 0 0 0 0 0 0 0 0 0 0 74 26 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 652 R H e 45.5 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 74 0 0 0 26 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 653 Q H e 20.9 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 1 0 0 18 0 1 0 0 43 1 0 0 0 32 0 1 1 1 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 654 Y H b 7.0 7v61_B 1 0 0 1 0 1 0 0 1 1 0 0 0 0 0 1 1 23 0 68 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 655 F H b 5.3 7v61_B 1 0 0 1 42 1 0 0 1 1 0 27 23 0 0 1 1 1 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 656 L H e 49.4 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 1 0 0 1 0 1 0 27 1 12 0 23 0 0 0 31 1 1 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 657 K H e 63.7 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[750 aa] 0 0 0 12 0 0 0 7 26 0 0 0 0 0 29 0 26 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 658 V T e 45.3 7v61_B 6 0 0 29 0 0 0 33 0 0 0 0 0 0 0 0 0 32 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 659 K S e 33.0 7v61_B 15 0 0 26 0 0 0 0 35 0 0 0 9 0 6 0 8 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 660 N e 84.8 7v61_B 0 0 0 0 0 26 0 0 0 0 0 51 0 0 0 0 23 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 661 Q e 47.4 7v61_B 0 0 0 29 0 0 0 0 0 0 0 0 0 35 9 26 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 662 M e 76.8 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[748 aa] 0 0 0 9 0 0 0 23 26 0 11 0 0 0 0 0 30 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 663 I e 25.7 7v61_B 2 1 2 2 1 2 1 51 2 3 1 1 2 1 2 2 2 21 0 1 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 664 L e 59.6 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa] 2 1 2 2 1 2 1 2 2 47 1 1 26 1 2 2 2 2 0 1 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 665 F b 1.4 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa] 2 1 2 2 43 2 1 2 2 29 1 1 2 1 2 2 2 2 0 1 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 666 G b 16.7 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 4 1 3 3 2 36 1 3 3 11 1 2 3 2 3 3 3 14 1 2 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 667 E G e 26.6 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 2 0 1 69 1 2 1 1 1 2 1 1 1 1 1 2 11 1 0 1 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 668 E G e 58.3 7v61_B 6 0 18 27 0 0 0 0 26 0 0 0 0 0 0 23 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 669 D G b 1.2 7v61_B 0 0 24 0 0 0 32 0 0 0 0 18 0 0 0 26 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 670 V E b 4.0 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 26 74 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 671 R E b 17.4 7v61_B 0 0 0 26 0 0 0 0 0 32 0 0 0 0 18 0 0 0 24 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 672 V E e 26.7 7v61_B 0 0 0 0 0 0 0 0 0 32 0 0 0 0 0 0 0 68 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 673 A E b 10.7 7v61_B 11 32 0 0 0 0 0 0 0 0 0 0 0 0 0 57 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 674 N E e 58.2 7v61_B 0 0 25 0 0 0 0 0 0 0 0 75 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 675 L E e 52.2 7v61_B 0 0 0 0 0 0 0 10 9 50 0 0 0 0 0 0 0 31 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 676 K E e 56.1 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa]:SIT1[579 aa] 0 0 0 0 0 0 0 0 59 0 0 0 0 0 0 0 41 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 677 P T e 98.4 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:SIT1[579 aa] 0 0 0 0 0 0 0 0 0 0 0 0 59 41 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 678 R T e 51.0 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa]:SIT1[579 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 679 I T b 10.5 7v61_B 0 0 0 0 0 0 0 41 0 0 0 0 0 0 0 0 0 59 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 680 S E b 8.6 7v61_B S6A19_HUMAN:Sodium-dependent neutral amino acid transporter B(.. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 681 F E b 0.0 7v61_B 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 682 N E e 25.5 7v61_B 0 0 0 0 0 0 0 0 9 0 0 40 0 0 0 0 0 0 41 9 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 683 F E b 0.5 7v61_B 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 684 F E b 2.9 7v61_B 0 0 0 0 59 0 0 0 0 0 0 0 0 0 0 0 0 41 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 685 V E b 0.7 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 686 T E b 0.6 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 687 A E b 11.6 7v61_B 23 0 41 0 9 0 0 0 0 0 0 0 0 0 0 27 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 688 P T e 33.3 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 84 0 0 16 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 689 K T e 75.0 7v61_B NAG 0 0 0 0 0 0 0 0 32 10 0 18 0 9 0 31 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 690 N E e 46.7 7v61_B NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 0 0 0 0 0 0 0 21 0 0 69 0 0 11 0 0 0 0 0 CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 691 V E b 13.3 7v61_B 3 1 2 3 2 3 1 2 2 4 1 2 2 2 2 3 2 62 1 1 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 692 S E b 18.0 7v61_B 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 0 0 0 0 0 0 0 0 0 0 41 0 0 0 59 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 693 D E e 48.8 7v61_B 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 0 59 0 0 0 31 0 0 0 0 0 0 0 0 0 0 0 0 10 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 694 I E e 28.7 7v61_B 0 0 0 0 0 0 0 33 0 0 0 0 0 0 0 0 41 26 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 695 I b 9.9 7v61_B 0 0 0 0 0 0 0 59 0 41 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 696 P e 41.1 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 697 R H e 27.3 7v61_B 41 0 0 0 0 0 0 0 0 0 0 0 0 0 59 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 698 T H e 53.9 7v61_B 20 0 0 0 0 0 0 0 0 0 0 0 0 0 0 34 25 21 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 699 E H e 26.6 7v61_B 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 700 V H b 2.7 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 701 E H e 20.6 7v61_B 0 0 0 59 0 0 0 0 0 0 0 0 0 41 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 702 K H e 47.6 7v61_B 0 0 18 16 0 0 0 0 16 0 0 9 0 0 0 41 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 703 A H b 0.0 7v61_B 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 704 I H b 0.0 7v61_B 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 705 R H e 41.1 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 706 M H e 39.1 7v61_B 0 0 0 0 0 0 0 0 10 9 81 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 707 S S b 9.4 7v61_B 0 0 0 0 0 0 0 0 0 0 0 41 0 0 0 59 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 708 R H b 7.1 7v61_B 0 0 0 0 0 0 0 0 10 0 0 0 0 0 90 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 709 S H e 65.6 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 0 0 9 0 0 18 0 0 0 0 0 41 0 0 0 32 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 710 R H e 58.1 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 711 I H b 1.2 7v61_B 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 712 N H b 5.5 7v61_B 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 713 D H e 75.9 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 0 0 59 0 0 0 0 0 0 0 0 21 0 0 0 20 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 714 A H e 43.8 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 73 0 0 0 0 0 0 8 0 0 0 0 0 0 0 0 0 19 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 715 F T b 1.4 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 716 R T e 71.1 7v61_B ACE2_HUMAN:Angiotensin-converting enzyme 2[748 aa]:Angiotensin-converting enzyme 2[749 aa]:Angiotensin-converting enzyme 2[711 aa]:Angiotensin-converting enzyme 2[751 aa]:Angiotensin-converting enzyme 2[750 aa] 0 0 0 0 41 18 0 0 0 0 0 0 0 9 32 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 717 L b 2.8 7v61_B 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 718 N e 63.0 7v61_B 0 0 46 0 0 0 0 0 0 0 0 54 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 719 D S e 35.2 7v61_B 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 720 N S e 73.3 7v61_B 0 0 0 0 0 0 20 0 0 0 0 59 0 21 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" N->D:LB/B:-: -; 721 S S b 2.3 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 59 41 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 722 L E b 0.0 7v61_B 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 723 E E e 27.6 7v61_B 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 724 F b 0.0 7v61_B 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 725 L S e 33.1 7v61_B 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 726 G S e 45.2 7v61_B 0 0 0 0 0 59 0 0 31 0 0 0 0 0 11 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 727 I b 3.5 7v61_B 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 728 Q e 59.2 7v61_B S6A20_HUMAN:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa] 0 0 0 9 0 0 9 0 0 0 0 0 41 33 0 0 0 0 0 8 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 729 P e 65.9 7v61_B S6A20_HUMAN:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[579 aa] 0 0 0 0 0 0 0 0 0 0 0 0 59 0 0 41 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 730 T e 61.7 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa]:SIT1[579 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 731 L e 92.7 7v61_B 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 732 G e 77.4 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[579 aa] 41 0 0 9 0 25 0 0 8 0 0 0 0 0 0 16 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 733 P e 90.7 7v61_B S6A19_HUMAN:Sodium-dependent neutral amino acid transporter B(.. 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 734 P e 103.9 7v61_B S6A19_HUMAN:Sodium-dependent neutral amino acid transporter B(.. 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 735 N e 85.5 7v61_B 0 0 0 0 0 0 0 0 0 0 31 16 0 0 0 0 11 0 0 43 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 736 Q e 74.0 7v61_B S6A19_HUMAN:Sodium-dependent neutral amino acid transporter B(.. 0 0 31 28 0 0 0 0 0 0 0 0 0 33 9 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 737 P e 46.5 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 738 P S e 96.1 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 59 0 0 41 0 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 739 V S e 55.3 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 740 S e 39.8 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 41 0 0 16 43 0 0 0 DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Extracellular" 741 I T e 62.0 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa]:SIT1[579 aa] 0 0 0 0 0 0 0 80 0 0 0 0 0 0 0 0 0 20 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 742 W H e 71.7 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa]:SIT1[579 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 743 L H e 41.0 7v61_B 0 0 0 0 0 0 0 41 0 59 0 0 0 0 0 0 0 0 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 744 I H e 55.0 7v61_B 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 745 V H e 59.3 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa]:SIT1[579 aa] 0 0 0 0 0 0 0 48 0 0 0 0 0 0 0 0 0 52 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 746 F H e 52.6 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa]:SIT1[579 aa] 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 747 G H e 44.0 7v61_B 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 748 V H e 68.7 7v61_B 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 749 V H e 55.3 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa] 0 0 0 0 0 0 0 41 0 0 0 0 0 0 0 0 0 59 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 750 M H e 42.0 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:SIT1[579 aa] 0 0 0 0 41 0 0 0 0 0 59 0 0 0 0 0 0 0 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 751 G H e 38.1 7v61_B 9 41 0 0 0 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 752 V H e 60.7 7v61_B 9 0 0 0 0 0 0 41 0 9 0 0 0 0 0 0 8 33 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 753 I H e 55.6 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa]:SIT1[579 aa] 0 0 0 0 0 0 0 34 0 0 0 0 0 0 0 0 0 66 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 754 V H e 46.7 7v61_B 0 0 0 0 0 0 0 10 0 11 0 0 0 0 0 0 20 59 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 755 V H e 56.7 7v61_B 0 0 0 0 0 0 0 9 0 0 0 0 0 0 0 0 0 91 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 756 G H e 39.3 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[579 aa] 41 0 0 0 0 59 0 0 0 0 0 0 0 0 0 0 0 0 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 757 I H e 56.7 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa]:SIT1[579 aa] 0 0 0 0 0 0 0 89 0 0 0 0 0 0 0 0 11 0 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 758 V H e 43.3 7v61_B 31 0 0 0 0 0 0 9 0 0 11 0 0 0 0 0 0 50 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 759 I H e 56.1 7v61_B 0 0 0 0 0 0 0 25 0 57 0 0 0 0 0 0 0 17 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 760 L H e 64.0 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa]:SIT1[579 aa] 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 761 I H e 56.1 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:SIT1[579 aa] 0 0 0 0 0 0 0 80 0 0 0 0 0 0 0 0 0 20 0 0 TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like":TRANSMEM:/note="Helical":DOMAIN:/note="Collectrin-like" 762 F H e 70.3 7v61_B 0 0 0 0 25 0 0 11 0 31 0 0 0 0 0 0 0 34 0 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 763 T H e 48.7 7v61_B S6A19_HUMAN:Sodium-dependent neutral amino acid transporter B(.. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 57 43 0 0 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 764 G H e 48.8 7v61_B S6A19_HUMAN:Sodium-dependent neutral amino acid transporter B(.. 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 765 I H e 55.6 7v61_B S6A20_HUMAN:SIT1[579 aa] 3PH 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 766 R H e 80.6 7v61_B 0 0 0 0 0 0 0 0 18 0 0 0 0 0 72 0 0 0 10 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 767 D H e 90.1 7v61_B 0 0 16 0 0 18 0 0 0 0 0 25 0 41 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 768 R e 79.8 7v61_B S6A19_HUMAN:S6A20_HUMAN:Sodium-dependent neutral amino acid transporter B(..:Sodium- and chloride-dependent transporter XTRP3[5..:SIT1[573 aa]:SIT1[579 aa] 0 0 0 0 0 0 11 0 0 0 0 0 0 0 89 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 769 K 0 0 0 0 0 0 0 0 33 0 0 0 0 0 67 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 770 K 0 0 0 0 0 0 0 0 59 0 0 0 0 0 41 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 771 K 0 0 0 0 0 0 0 0 63 0 0 37 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 772 N 0 0 9 0 0 0 0 0 10 0 0 81 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 773 K 0 0 0 18 0 0 0 0 57 0 0 0 0 25 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 774 A 41 0 0 10 0 31 0 0 0 0 0 0 0 0 0 0 18 0 0 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 775 R 0 0 0 0 0 9 0 0 18 0 0 0 41 0 23 9 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 776 S 0 0 0 0 0 0 0 0 0 0 0 8 20 0 18 54 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 777 G 0 21 0 51 0 28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 778 E 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 779 N 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 780 P 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 781 Y 0 31 0 0 0 0 0 0 0 0 0 0 0 0 0 10 0 0 0 59 MOD_RES:/note="Phosphotyrosine" ECO:0000305|PubMed:33436498":MOTIF:/note="Endocytic sorting signal" ECO:0000305|PubMed:33436498":MOTIF:/note="SH2-binding" ECO:0000305|PubMed:33436498":MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOD_RES:/note="Phosphotyrosine" ECO:0000305|PubMed:33436498":MOTIF:/note="Endocytic sorting signal" ECO:0000305|PubMed:33436498":MOTIF:/note="SH2-binding" ECO:0000305|PubMed:33436498":MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 782 A 32 0 59 0 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MOTIF:/note="Endocytic sorting signal" ECO:0000305|PubMed:33436498":MOTIF:/note="SH2-binding" ECO:0000305|PubMed:33436498":MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOTIF:/note="Endocytic sorting signal" ECO:0000305|PubMed:33436498":MOTIF:/note="SH2-binding" ECO:0000305|PubMed:33436498":MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 783 S 0 0 0 0 0 0 0 0 0 0 0 0 41 0 0 59 0 0 0 0 MOD_RES:/note="Phosphoserine" ECO:0000305|PubMed:33436498":MOTIF:/note="Endocytic sorting signal" ECO:0000305|PubMed:33436498":MOTIF:/note="SH2-binding" ECO:0000305|PubMed:33436498":MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOD_RES:/note="Phosphoserine" ECO:0000305|PubMed:33436498":MOTIF:/note="Endocytic sorting signal" ECO:0000305|PubMed:33436498":MOTIF:/note="SH2-binding" ECO:0000305|PubMed:33436498":MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 784 I 0 0 0 0 0 0 0 16 0 41 18 0 0 0 0 0 0 25 0 0 MOTIF:/note="Endocytic sorting signal" ECO:0000305|PubMed:33436498":MOTIF:/note="SH2-binding" ECO:0000305|PubMed:33436498":MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOTIF:/note="Endocytic sorting signal" ECO:0000305|PubMed:33436498":MOTIF:/note="SH2-binding" ECO:0000305|PubMed:33436498":MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 785 D 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MOTIF:/note="SH2-binding" ECO:0000305|PubMed:33436498":MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOTIF:/note="SH2-binding" ECO:0000305|PubMed:33436498":MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 786 I 0 0 0 0 0 0 0 33 0 25 41 0 0 0 0 0 0 0 0 0 MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOTIF:/note="LIR" ECO:0000305|PubMed:33436498":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 787 S 0 0 0 0 0 18 0 0 41 0 0 18 0 0 0 23 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 788 K 0 0 0 0 0 41 0 0 59 0 0 0 0 0 0 0 0 0 0 0 CROSSLNK:/note="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)":MUTAGEN:/note="K->R: Increases ACE2 protein stability.":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":CROSSLNK:/note="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)":MUTAGEN:/note="K->R: Increases ACE2 protein stability.":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 789 G 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 790 E 0 0 0 59 0 0 41 0 0 0 0 0 0 0 0 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 791 N 0 0 0 0 0 0 0 41 0 0 0 41 0 0 0 18 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 792 N 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 MOTIF:/note="PTB" ECO:0000305|PubMed:33436498":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOTIF:/note="PTB" ECO:0000305|PubMed:33436498":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 793 P 18 0 41 0 0 0 0 0 0 0 0 0 32 0 0 9 0 0 0 0 MOTIF:/note="PTB" ECO:0000305|PubMed:33436498":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOTIF:/note="PTB" ECO:0000305|PubMed:33436498":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 794 G 21 0 0 0 0 79 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MOTIF:/note="PTB" ECO:0000305|PubMed:33436498":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOTIF:/note="PTB" ECO:0000305|PubMed:33436498":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 795 F 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MOTIF:/note="PTB" ECO:0000305|PubMed:33436498":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOTIF:/note="PTB" ECO:0000305|PubMed:33436498":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 796 Q 0 0 0 0 0 0 0 0 0 20 10 0 0 59 0 0 0 11 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 797 N 0 0 0 0 0 0 16 0 0 0 0 43 0 0 0 0 41 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 798 T 16 0 0 41 0 0 0 9 0 0 0 0 0 0 0 18 16 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 799 D 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 800 D 0 0 59 41 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 801 V 18 0 0 0 0 0 0 0 0 0 0 0 0 0 41 0 0 41 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 802 Q 0 0 0 0 0 0 0 0 0 41 0 0 0 59 0 0 0 0 0 0 MUTAGEN:/note="QTSF->AAAA: Loss of interaction with NHERF1.":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MUTAGEN:/note="QTSF->AAAA: Loss of interaction with NHERF1.":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 803 T 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 MOTIF:/note="PDZ-binding" ECO:0000305|PubMed:33436498":MUTAGEN:/note="QTSF->AAAA: Loss of interaction with NHERF1.":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOTIF:/note="PDZ-binding" ECO:0000305|PubMed:33436498":MUTAGEN:/note="QTSF->AAAA: Loss of interaction with NHERF1.":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 804 S 0 0 0 0 0 0 0 0 0 0 0 0 26 0 0 74 0 0 0 0 MOTIF:/note="PDZ-binding" ECO:0000305|PubMed:33436498":MUTAGEN:/note="QTSF->AAAA: Loss of interaction with NHERF1.":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOTIF:/note="PDZ-binding" ECO:0000305|PubMed:33436498":MUTAGEN:/note="QTSF->AAAA: Loss of interaction with NHERF1.":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like" 805 F 0 0 0 0 62 0 0 0 0 38 0 0 0 0 0 0 0 0 0 0 MOTIF:/note="PDZ-binding" ECO:0000305|PubMed:33436498":MUTAGEN:/note="QTSF->AAAA: Loss of interaction with NHERF1.":COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like":MOTIF:/note="PDZ-binding" ECO:0000305|PubMed:33436498":MUTAGEN:/note="QTSF->AAAA: Loss of interaction with NHERF1.":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="Collectrin-like"